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Abstract: In the ovaries, many members of the FGF family are involved in the 
regulation of folliculogenesis. One of these members, FGF9, has been characterized 
as an anti-differentiation factor for its effects on steroidogenesis of granulosa (GC) 
and theca cells (TC) of cattle, but whether endogenous production of FGF9 changes 
during follicular development of cattle was unknown. Also, in order to have a 
comprehensive view of how FGFs regulate folliculogenesis, information of how 
endogenous production of their receptors (FGFRs) is also required. The first 
objectives of our studies presented herein was to characterize FGF9, FGFR1c, 
FGFR2c, FGFR3c, and FGFR4 mRNA abundance in GC and TC during development 
of dominant follicles in dairy cattle. Estrous cycles of non-lactating dairy cattle were 
synchronized, and ovaries were collected on either day 3-4 (n = 8) or day 5-6 (n = 8) 
post-ovulation for GC and TC mRNA extraction from small (1-5 mm), medium (5.1-8 
mm) or large (8.1-18 mm) follicles for PCR analysis. In GC, FGF9, FGFR1c, 
FGFR2c, and FGFR3c mRNA abundance was greater (P < 0.05) in estrogen (E2)-
inactive (i.e., concentrations of E2 < progesterone, P4) follicles than in large E2-
active (i.e., concentrations of E2 > P4) follicles. In TC, FGF9 mRNA abundance was 
greater (P < 0.05) in large E2-inactive follicles than in large E2-active follicles on day 
3-4 post-ovulation whereas medium E2-inactive follicles have greater (P < 0.05) 
FGFR1c and FGFR4 mRNA abundance than large E2-active and E2–inactive 
follicles on day 5-6 post-ovulation. In addition, FGFR1c, FGFR2c, FGFR3c, and 
FGFR4 mRNA abundance was greater (P < 0.05) in medium E2-inactive follicles on 
day 5-6 post-ovulation than on day 3-4 post-ovulation. Following, we aimed to 
investigate effects of FGF9 on TC through the use of microarray (Affymetrix 
GeneChip Bovine Genome Arrays) and the bioinformatic tool Ingenuity Pathway 
Analysis. This software identified differentially expressed transcripts in 346 pathways 
in response to FGF9 in TC involved in functions such as cell cycle, proliferation, 
survival, and steroidogenesis. Taken together, these studies reinforce the importance 
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Fibroblast growth factors (FGFs) are polypeptides described to elicit a great variety 
of actions throughout the system of mammals during embryo development and adult life, 
including organogenesis, sex determination (Kim et al., 2006), angiogenesis (Cross and 
Claesson-Welsh, 2001; Robinson et al., 2008), and wound healing (Zheng et al., 2014). Also, 
aberrant FGF signaling has been associated with cancer. In fact, the involvement of FGF 
signaling in cancer incidence has been extensively studied in the last decades, showing the 
importance of these mitogens for health (Ornitz and Itoh, 2001; Gotoh, 2008; Nakao et al., 
2013; Tanner and Grose, 2016). Moreover, there is an increasing body of studies throwing 
light on the functions of FGFs in the reproduction.  
Currently, out of the 22 members of the mammalian FGF family, ten have been 
reported to be synthesized at different degrees in the oocyte, theca cells (TC), and granulosa 
cells (GC), playing autocrine, paracrine, and endocrine roles in the ovary (Drummond et al., 
2007; Machado et al., 2009; Portela et al., 2010; Schreiber and Spicer, 2012; Castilho et al., 
2015; Ferreira et al., 2016). These roles include regulation of steroidogenesis (Baird and 
Hsueh, 1986; Vernon and Spicer, 1994; Schreiber and Spicer, 2012), cell proliferation 
(Gospodarowicz et al., 1977a; Parrott et al., 1994; Spicer and Stewart, 1996; Schreiber et al., 
2012), corpus luteum formation (Gospodarowicz et al., 1977b; Grazul-Bilska et al., 1995; 
Robinson et al., 2008), and atresia (Portela et al., 2015). 
 Among FGFs that regulate folliculogenesis of cattle, FGF9 stimulates GC 
proliferation while suppressing hormone-stimulated estradiol production (Schreiber and 




dominant follicles (Knecht et al., 1985; Fortune et al., 2004), FGF9 appears to have an anti-
differentiation function during ovarian follicular development of cattle. Whether endogenous 
production of FGF9 by ovarian follicular cells change during ovarian follicular growth and 
selection of cattle remains to be determined. Because FGF9 stimulates bovine TC 
proliferation while inhibiting steroidogenesis (Schreiber et al., 2012), studies to investigate 
FGF9 signaling mechanisms in TC of cattle are of great value for the understanding of how 
FGFs affect folliculogenesis in mono-ovulatory species. Advances in biotechnology and 
bioinformatics tools achieved in the last decades, such as the technology of cDNA 
microarray, which allows simultaneous measurement of thousands of gene transcripts 
(Schena et al., 1995), are critical for such an investigation. Nevertheless, interpretation of data 
generated by this tool is complex (Bowtell, 1999; Huang et al., 2009; Henderson-MacLennan 
et al., 2010) and would not be possible without the use of modern bioinformatics tools 
(Subramanian et al., 2005; Capriotti et al., 2012). Therefore, advances in bioinformatics 
technology for microarray-based genomic profiling provide an inestimable contribution to the 
advance in understanding the roles of various factors in reproductive biology. 
To elicit their intracellular actions, FGFs must bind to high affinity single chain 
transmembrane tyrosine kinase receptors (FGFRs), which have different ligand-specificities 
and are encoded by four different genes in vertebrates (Itoh and Ornitz, 2004; Ornitz and Itoh, 
2015): FGFR1, FGFR2, FGFR3, and FGFR4. The diversity of these receptors is further 
increased by the occurrence of alternative mRNA splicing of the sequence of the 
immunoglobulin domain III of the genes FGFR1, FGFR2, and FGFR3, resulting in isoforms 
IIIb and IIIc, which are important for determining ligand-binding specificity (Givol and 
Yayon, 1992; Ornitz and Itoh, 2001; Itoh and Ornitz, 2004; Li et al., 2016). Due to the 
different ligand-binding specificities (Ornitz and Itoh, 2015), the localization of FGFRs in the 
different follicle compartments is of critical importance for the FGFs to exert their effects on 
ovarian physiology. Indeed, there is variation in the presence of isoforms of FGFRs in GC, 




Ealy, 2012), contributing to the variation in effects of different FGFs observed in 
folliculogenesis of mammals. Some FGFRs change according to follicular fate (Berisha et al., 
2004; Buratini et al., 2005a; Castilho et al., 2015), adding complexity to the roles of FGFs in 
ovarian follicular development. Therefore, studies about how endogenous production of some 
FGFRs by ovarian follicular cells change during selection of dominant follicles in a 
monotocous species such as cattle are very much needed for a comprehensive understanding 











REVIEW OF LITERATURE 
 
1. Fibroblast growth factors family of proteins and their receptors 
Fibroblast growth factors (FGFs) constitute a large family of single chain polypeptide 
growth factors present in both vertebrates and invertebrates (Ornitz and Itoh, 2001; Dailey et 
al., 2005; Itoh and Ornitz, 2011; Li et al., 2016). The first members to be reported, FGF1 and 
FGF2, were designated acidic and basic FGF in view of their activity to stimulate fibroblast 
proliferation and their isoelectric point (Armelin, 1973; Gospodarowicz, 1974; Gambarini and 
Armelin, 1982). To date, 22 different members of the FGF family have been described in 
mammals (FGF 1-23, with no FGF15 identified in humans, and no FGF19 identified in rats 
and mice), most of them sharing highly conserved amino acid residues (Ornitz and Itoh, 2001; 
Itoh and Ornitz, 2011). These members can be categorized into several subgroups or 
subfamilies according to increased similarity in sequence, patterns of expression, function, 
and developmental and biochemical features, although each FGF still appears to have 
particular sites of expression (Ornitz and Itoh, 2001).  
Currently, mammalian FGFs are classified into seven subfamilies containing two to 
four members each (Itoh and Ornitz, 2011; Li et al., 2016), as summarized in Table 1. These 
subfamilies can also be categorized into two general groups: the canonical FGFs, which 
comprise most of the members, and the non-canonical FGFs, which comprise members 11 to 
14 (as reviewed by Li et al., 2016). The canonical FGFs exert autocrine, paracrine, and 




canonical FGFs do not bind to FGFRs and act intracellularly through interaction with calcium 
and voltage-gated sodium channels (Wang et al., 2011; Hennessey e al., 2013; Li et al., 2016). 
The majority of FGFs have an N-terminal signal peptide (Table 1) that facilitates 
secretion from cells through classical mechanisms (Ornitz & Itoh, 2001; Li et al., 2016). A 
second group of FGFs, including FGF1 (Prudovsky et al., 2003), FGF2 (Abraham et al., 
1986; La Venuta et al., 2015; Steringer et al., 2015), FGF9 (Miyamoto et al., 1993; Miyakawa 
et al., 1999), FGF16 (Miyake et al., 1998), and FGF20 (Ohmachi et al., 2000), lacks a 
cleavable signal peptide and its members are secreted in a non-conventional manner, 
including through membrane pores, independently of the endoplasmic reticulum-Golgi 
pathway (for reviews, see Ornitz & Itoh, 2001; Li et al., 2016). Finally, a third group of FGFs 
(FGF 11 to FGF 14) lacks signal sequences and is believed to remain inside the cell (as 
reviewed by Ornitz and Itoh, 2001). 
As mentioned, FGFs were first reported to promote fibroblast proliferation (Armelin, 
1973; Gospodarowicz, 1974), but the functions of these polypeptides go much beyond of 
what the name implies. In fact, the name nowadays could be considered misleading, given 
that not all FGFs elicit activity in fibroblasts (Rubin et al., 1989; Powers et al., 2000; Li et al., 
2016). FGFs have been detected in various tissues, playing several roles in development and 
metabolism, with some members acting exclusively during embryogenesis and others acting 
in both embryonic and adult tissues (Ornitz and Itoh, 2001). These growth factors can act to 
stimulate cell steroidogenesis (Johnson et al., 1980), proliferation (Gospodarowicz et al., 
1977a; Murphy et al., 1990), survival (Gospodarowicz and Bialecki, 1978; Sievers et al., 
1987), differentiation (Stemple et al., 1988; Dailey et al., 2005), and migration (Montesano et 
al., 1986), but they can also prevent cell proliferation (Oesterle et al., 2000) and inhibit 
differentiation (Joannes et al., 2016). Interestingly, the action of FGFs vary not just according 
to the cell type, but also to cell cycle stage, with different responses observed in immature and 




The wide range of the functions of FGFs is influenced by the diversity of high 
affinity FGFRs and cofactors that regulate the FGF signaling complex. To date, four (FGFR1-
FGFR4) receptors and several cofactors, including heparan sulfates (HS) and Klotho 
coreceptors  have been identified (Givol and Yayon, 1992; Itoh and Ornitz, 2004; Dailey et 
al., 2005; Li et al., 2016). The FGFRs are tyrosine kinase receptors that have different ligand-
specificities (table 2) and are encoded by four different genes in vertebrates (Itoh and Ornitz, 
2004; Ornitz and Itoh, 2015). The extracellular ligand-binding portion of FGF receptors 
contains two or three immunoglobulin-like domains, and a heparin-binding domain 
(Plotnikov et al., 2000; Itoh and Ornitz, 2004). Immunoglobulin domains have a characteristic 
fold built up of a sandwich of two β sheets containing antiparallel strands linked by a 
disulphide bond. These domains have no enzymatic activity, but are important for 
determining ligand specificity (Dell and Williams, 1992; Barclay, 2003). Alternative mRNA 
splicing of the FGFR genes regulates the number (two or three) of immunoglobulin domains 
and dictates the sequence of the immunoglobulin domain III, resulting in isoforms IIIb and 
IIIc, which are important for determining ligand-binding specificity (Givol and Yayon, 1992; 
Ornitz and Itoh, 2001; Itoh and Ornitz, 2004). This splicing naturally occurs in the FGFR1, 
FGFR2, and FGFR3 genes, but not in the FGFR4 gene (as reviewed by Li et al., 2016). 
The HS cofactors are components of proteoglycans on the cell surface and in the 
pericellular matrix that bind both FGF and FGFR to facilitate and stabilize their interaction 
(Yayon et al., 1991; Mohammadi et al., 2005; Li et al., 2016). For endocrine FGFs (including 
FGF19, FGF21, and FGF23), that have little affinity for HS, the transmembrane proteins 
Klotho/betaKlotho are important to facilitate binding to FGFRs (Goetz et al., 2007). Variation 
in sulfated domains of HS and in affinity to cofactors contribute to differences in FGF 
signaling activities in addition to FGFRs diversity (Guimond and Turnbull, 1999; Merry et 
al., 1999; Ye et al., 2001).  
The binding of ligands to FGFRs causes receptor dimerization, transphosphorylation, 




tyrosine kinase takes part in signal transduction to the nucleus, stimulating mitogenesis 
(Radha et al., 1996; Ruetten and Thiemermann, 1997). Tyrosine autophosphorylation of 
receptors by tyrosine kinase is essential for the recruitment and activation by phosphorylation 
of many downstream cytoplasmic targets and subsequent initiation of dynamic signaling 
cascades (Dengjel et al., 2009; Goetz and Mohammadi, 2013). The main signaling pathways 
downstream of receptors for tyrosine kinase are: Ras/MAPK (mitogen-activated protein 
kinase) signaling cascades, which regulate cell proliferation; signaling pathways involving 
phospholipid second messengers via PLCγ (phospholipase C-γ) for regulation of cell motility; 
PI3K (phosphatidylinositol 3-kinase) for regulation of cell survival; and the STATs (signal 
transducers and activator of transcription) pathway (Dengjel et al., 2009; Goetz and 
Mohammadi, 2013). Nevertheless, for activation of the Ras/MAPK and the PI3K pathways to 
occur, the docking protein FRS2α needs to be phosphorylated in its tyrosine and 
serine/threonine residues, which occurs upon binding of FGF to its receptor (Kouhara et al., 
1997; Gotoh, 2008; Ornitz and Itoh, 2015). The specificity of signal transduction at this initial 
stage is determined in great extent by the amino acid sequence surrounding the 
phosphorylated tyrosine residue (Dengjel et al., 2009).  
2. Role of fibroblast growth factors on ovarian physiology  
FGFs were first reported in the ovary in 1977 (Gospodarowicz et al., 1977b; 
Gospodarowicz et al., 1977c), when FGF1 was found to stimulate proliferation of bovine 
granulosa cells (GC) and theca cells (TC). From these pioneer studies to present, ten members 
of the FGF family have been described in the ovary of mammals, including FGF1 (Berisha et 
al., 2004), FGF2 (Berisha et al., 2000), FGF7 (Parrott and Skinner, 1998), FGF8 (Buratini et 
al., 2005a), FGF9 (Drummond et al., 2007; Schreiber and Spicer, 2012), FGF10 (Castilho et 
al., 2015), FGF16 (Ferreira et al., 2016), FGF17 (Machado et al., 2009), FGF18 (Portela et 




roles in the regulation of development of ovarian follicles (for reviews, see Chaves et al., 
2012; Price, 2016). 
Ovarian folliculogenesis is a highly regulated process by which the female oocyte 
develops within the somatic cells of the ovary, GC and TC, and matures into a fertilizable 
ovum (Eppig, 1991; Richards, 1994; Elvin and Matzuk, 1998; McGee and Hsueh, 2000; 
Ackert et al., 2001). Ovarian follicles develop through primordial, primary, and secondary 
stages before an antral cavity is formed (McGee and Hsueh, 2000). These preantral follicles 
remain in a dormant stage until primordial follicle activation occurs, followed by growth of 
both the oocyte and follicle somatic cells (Fortune et al., 2000). This process happens in the 
fetal life of domestic animals and primates and in early neonatal period of rodents and rabbits 
(Hirshfield, 1991; Van den Hurk et al., 1997; Fortune et al., 2000; Fortune, 2003).  
The factors that stimulate development of preantral follicles are dependent on species 
and stage of follicles and include insulin, growth differentiation factor-9 (GDF-9), estradiol, 
insulin-like growth factor-1 (IGF-1), epidermal growth factor (EGF), follicle stimulating 
hormone (FSH), and luteinizing hormone (LH), among others (McGee and Hsueh, 2000; 
Fortune, 2003; Hsueh et al., 2015). Nevertheless, the gonadotropins (FSH and LH) are 
unlikely to exert direct actions on primordial follicles because these structures lack 
gonadotropins receptors, so they start to be important beginning at the stage of primary 
follicles in some species, such as porcine and murine, and in small secondary follicles in other 
species, such as bovine (Hsueh et al., 1984; McGee and Hsueh, 2000; Fortune et al., 2003). 
Among the factors aforementioned, FGFs also have been reported to act in development of 
early stages of follicular development. 
The production of FGFs within the ovary starts early in folliculogenesis: FGF2 was 
found in oocytes of immature bovine follicles (van Wezel et al., 1995); FGF7 has been 
reported in primordial, primary, and secondary follicles of cattle (Berisha et al., 2004; 




stromal cells and basement membranes surrounding GC as well as in TC precursors 
(Drummond et al., 2007); FGF10 mRNA was detected in primordial, primary, and secondary 
follicles of cattle (Buratini et al., 2007). In addition, at least two members of the FGF family 
are reported to have an active role in preantral follicle development: FGF2 and FGF7. FGF2 
was found to stimulate GC proliferation of preantral follicles in cattle (Wandji et al., 1996), 
transition of primordial follicles into primary follicles in rats (Nilsson, et al., 2001) and 
preantral follicle growth and survival in women (Wang et al., 2014) while FGF7 was found to 
stimulate preantral follicle development in rats (Hsueh et al., 2000; Kezele et al., 2005). 
These observations imply a role of FGFs in early folliculogenesis. 
Members of the FGF family were also detected in antral follicles and in corpora lutea 
(Parrott and Skinner, 1998; Berisha et al., 2000; Castilho et al., 2008; Cho et al., 2008). After 
acquiring an antral cavity, a small group of follicles is recruited to initiate follicular growth 
towards ovulation (Bao and Garverick, 1998). Nevertheless, most of them undergo atretic 
degeneration while only a few of them will be selected to become the dominant follicles, 
which are larger than the subordinate follicles and will ovulate to release the mature oocyte 
for fertilization (Spicer and Echternkamp, 1986; McGee and Hsueh, 2000). The recruitment 
of a cohort of growing antral follicles and subsequent selection of dominant follicles is not 
only regulated by gonadotropic hormones, but also by factors produced by the oocyte and 
surrounding follicular cells (Eppig, 2001; Fortune et al., 2004). Hence, the presence of FGFs 
in antral follicles indicates their importance in all stages of folliculogenesis. 
In antral follicles of cattle, FGF1, FGF2, FGF7, FGF18, and FGF22 are mainly 
produced by TC (Parrott and Skinner, 1998; Berisha et al., 2000; Berisha et al., 2004; Buratini 
et al., 2007; Portela et al., 2010; Castilho et al., 2015); FGF8 is produced by GC, TC, and 
oocytes (Buratini et al., 2005); FGF9 is produced in greater amounts in GC than in TC 
(Schreiber et al., 2012); FGF10 is produced by TC and oocytes (Buratini et al., 2007); FGF16 
is produced by the oocyte (Ferreira et al., 2016); and FGF17 is detected mainly in oocytes, 




change according to the diameter of bovine antral follicles: FGF2 and FGF7 mRNA 
abundance, for example, is greater in large than in small follicles (Parrott and Skinner, 1998; 
Berisha et al., 2000; Berisha et al., 2004) while FGF9 mRNA abundance is greater in small 
than in large follicles (Schreiber et al., 2012). Nevertheless, some FGFs such as FGF1 
(Berisha et a., 2004; Berisha et al., 2006) and FGF22 (Castilho et al., 2015) do not change 
during antral follicular growth in cattle. 
2.1 Role of fibroblast growth factors and gonadotropins on ovarian steroidogenesis 
In response to gonadotropins (FSH and LH) secreted by the pituitary, the different 
compartments of the ovarian follicle interact in a highly integrated way to synthesize and 
secrete sex steroids (estrogens, progestins) in order to produce a fertilizable egg (Hsueh et al., 
1984). Estradiol, the main estrogen produced in ovarian follicles, has direct effects on GC, 
stimulating cell proliferation, enhancing LH receptor formation and FSH-stimulated 
aromatase activity (Hsueh et al., 1984; Kessel et al., 1985), being therefore essential for 
development and survival of dominant follicles (Spicer and Echternkamp, 1986; Evans and 
Fortune, 1997; Robker and Richards, 1998). Besides providing an uterine environment to 
maintain pregnancy (Keyes and Wiltbank, 1988; Lonergan et al., 2007), progesterone also 
plays a role in the control of preovulatory follicle maturation: it increases close to the time of 
ovulation (Fortune and Hansel, 1995), regulates the time of release of prostaglandin F2α for 
luteolysis (Silvia et al., 1991; dos Santos et al., 2009), and regulates the release of LH and 
FSH by the pituitary, in addition to modulating pituitary responsiveness to gonadotropin-
releasing hormone (GnRH) from the hypothalamus (Chang and Jaffe, 1978; Mahesh and 
Muldoon, 1987). 
Follicular steroid production is crucial for maintenance and development of growing 
follicles and are dependent upon stimulation of FSH and LH, which regulate several key 
enzymes, such as cytochrome P450 side-chain cleavage enzyme (P450scc), cytochrome P450 
17α- hydroxylase (17αOH), 3β-hydroxysteroid dehydrogenase (3β-HSD), and cytochrome 




protein (StAR) (Richards, 1994; Tian et al., 1995; Bao and Garverick, 1998; McGee and 
Hsueh, 2000; Logan et al., 2002; Orisaka et al., 2006). Each of these enzymes catalyzes a key 
step in the biosynthesis of steroids and their expression changes according to the type of cell 
and stage of follicle development (Tian et al., 1995; Bao and Garverick, 1998; Logan et al., 
2002). As reviewed by Richards (1994), P450scc converts cholesterol into pregnenolone, 3β-
HSD converts pregnenolone into progesterone, 17αOH converts progesterone to 
androstenedione, and aromatase converts androgens into estrogens. 
LH plays a key role in determining the differentiation of TC in preovulatory follicles 
since, in these follicles, TC have high amounts of LH receptor and 17αOH and therefore 
synthesize great quantities of androgens (Richards, 1994; Tian et al., 1995; McGee and 
Hsueh, 2000). Androgens produced by TC are converted into estrogens by aromatase present 
in GC, and high concentrations of estrogens, in synergism with FSH, stimulate GC 
differentiation of large preovulatory follicles (Hsueh et al., 1984; Richards, 1994; McGee and 
Hsueh, 2000; Fortune et al., 2004). Moreover, in preovulatory follicles, FSH stimulates 
mRNA expression for P450scc, LH receptor, and StAR in GC, resulting in an increase in 
progesterone production by these cells (Orisaka et al., 2006). 
FGFs diverge in their effects over steroidogenesis and subsequently over follicular 
survival. To date, from the ten members of the FGF family detected in the ovary, at least eight 
have effects on ovarian steroidogenesis: FGF1, FGF2, FGF7, FGF8, FGF9, FGF10, FGF17, 
and FGF18. 
In cattle, FGF1 had no effect on progesterone production by GC (Schams et al., 
2001). In contrast, FGF1 stimulates progesterone production by ovine luteal cells collected 
from day 5 of the estrous cycle, with no effects on luteal cells collected on later stages (days 
10 and 15) of the estrous cycle (Grazul-Bilska et al., 1995). In pigs, FGF1 inhibited 
progesterone secretion by GC (Biswas et al., 1988), suggesting that differences exist among 




FGF2 effects on steroidogenesis have been extensively studied, indicating that FGF2 
inhibits FSH-stimulated estradiol production and aromatase activity by rat (Baird and Hsueh, 
1986; Yamoto et al., 1993) and bovine GC (Vernon and Spicer, 1994; Wandji et al., 1996). 
Also, FGF2 inhibits LH-stimulated progesterone and androstenedione production by bovine 
GC (Spicer and Stewart, 1996; Wandji et al., 1996). In contrast, FGF2 enhanced FSH-induced 
progesterone production by rat GC when FSH was used at suboptimal concentrations (Baird 
and Hsueh, 1986), and stimulated LH-induced production of both estradiol and progesterone 
by rat GC (Yamoto et al., 1993). These latter results imply that effects of FGF2 on 
steroidogenesis may change not only according to species, but also according to other factors 
such as the dose and type of gonadotropin used and developmental status of follicles when 
GC were collected. 
FGF7 inhibits FSH-stimulated estradiol production and aromatase activity by bovine 
and rat GC and suppresses hCG-stimulated progesterone production by bovine GC (Parrott 
and Skinner, 1998) and human GC (Osuga et al., 2001). 
FGF8 suppresses FSH-induced estradiol production by rat GC with no effects on 
production of progesterone and cAMP induced by FSH and forskolin (Miyoshi et al., 2010; 
Miyoshi et al., 2012). 
FGF9 has divergent roles on steroidogenesis, depending on the species. In rats, 
progesterone production by GC was increased by FGF9 when stimulated by FSH, but not by 
LH (Drummond et al., 2007), implying that the FGF9 stimulatory effect on progesterone 
production may be dependent on degree of differentiation of GC. Drummond and colleagues 
(2007) also observed a stimulatory effect of FGF9 in mRNA levels for the steroidogenic 
enzymes StAR and P450scc in rat GC, with an inhibitory effect of a high dose of FGF9 on 
3β-HSD mRNA in the presence of FSH. In pigs, FGF9 increased estradiol production by GC 
with inconsistent effects on progesterone production by GC, stimulating progesterone 




FSH and IGF1 (Evans et al., 2014). In cattle, in contrast to what was observed for rats and 
pigs, FGF9 attenuated GC production of progesterone and estradiol stimulated by IGF-1 
(Schreiber and Spicer, 2012). Schreiber and Spicer (2012) also showed that FGF9 decreased 
mRNA abundance for FSH receptor and the steroidogenic enzyme P450scc in GC of both 
small and large follicles with no effects on aromatase or StAR mRNA abundance. In bovine 
TC, FGF9 also had inhibitory effects on steroidogenesis, attenuating IGF-1 stimulated 
production of both androstenedione and progesterone and decreasing mRNA abundance for 
LH receptor and for P450scc enzyme and 17-α-hydroxylase in cells cultured with LH and 
IGF-1, with no effect on abundance of StAR mRNA (Schreiber et al., 2012). 
FGF10 not only suppresses FSH-stimulated estradiol production by bovine GC 
(Buratini et al., 2007), but also decreased mRNA abundance for FSH receptor and for 
aromatase, with no effects on mRNA levels for STAR or the steroidogenic enzymes 3β-HSD 
and P450scc (Castilho et al., 2015). 
FGF17 treatment decreased FSH-stimulated estradiol and progesterone secretion by 
bovine GC from small follicles in diameter (Machado et al., 2009).  
FGF18 is a powerful suppressor of ovarian steroidogenesis in cattle (Portela et al., 
2010), inhibiting FSH-stimulated estradiol and progesterone by GC in a dose-dependent 
manner as well as decreasing mRNA abundance for STAR and FSH receptor as well as 
decreasing aromatase, P450scc, 3β-HSD, and hydroxysteroid (17-β) dehydrogenase 1 mRNA 
abundance. 
2.2 Role of fibroblast growth factors in proliferation of granulosa and theca cells 
Members of the FGF family have been reported in many studies as powerful 
mitogens, acting in many organs and cell types to stimulate cell proliferation (for reviews, see 
Finch et al., 1989; Rodan et al., 1989; Igarashi et al., 1998; Skaletz-Rorowski et al., 1999; 




Ras/MAPK signaling cascades to stimulate cell proliferation (Dailey et al., 2005; Dengjel et 
al., 2009), as well as organ development (Hogan, 1999; Metzger and Krasnow, 1999), wound 
healing (Wahl et al., 1989; Li et al., 2016), tumor formation (Ornitz and Itoh, 2001; Tanner 
and Grose, 2015), and more recently, ovarian folliculogenesis (Chaves et al., 2012; Price, 
2016). 
In ovarian follicular development, the compartments of the follicles, namely oocyte, 
GC, and TC, communicate in paracrine ways to stimulate somatic cell proliferation and 
follicular development. Presently, at least four members of the FGF family are known to 
stimulate bovine ovarian follicle cell proliferation: FGF1, FGF2, FGF7, and FGF9 
(Gospodarowicz et al., 1977b; Gospodarowicz et al., 1977c; Gospodarowicz et al., 1985; 
Parrott et al., 1994; Spicer and Stewart, 1996; Schreiber and Spicer, 2012). In chickens, FGF1 
and FGF2 stimulate both GC and TC proliferation whereas FGF5 and FGF7 have no effect 
(Roberts and Ellis, 1999), suggesting that species differences may exist in terms of which 
FGF is mitogenic in the follicle. 
It has been proposed that oocytes carry out this intrafollicular conversation by 
secreting factors that affect GC morphology, which in turn affect the oocyte (Eppig, 2001; 
Matzuk et al., 2002) and theca interna (Liu et al., 2015). Indeed, among other factors, bone 
morphogenesis protein-15 (BMP-15) and GDF-9 are derived from mammalian oocytes to 
stimulate GC proliferation (Otsuka et al., 2000; Vitt et al. 2000; Spicer et al., 2006), TC 
proliferation, and theca interna development (Spicer et al., 2008; Liu et al., 2015). Within the 
FGF family, at least four members are currently known to be secreted by the oocyte of 
mammalian antral follicles, including FGF8, FGF10, FGF16, and FGF17 (Buratini et al., 
2005a; Buratini et al., 2007; Sugiura et al., 2007; Machado et al., 2009; Santos-Biase et al., 
2012; Ferreira et al., 2016), and only FGF8 appears to be stimulating GC proliferation, since 
it leads to expression of genes related to cell proliferation, such as MAPK3/1 and MAPK14, 




stimulating GC proliferation and if other FGFs are produced by the oocyte to stimulate 
proliferation of surrounding somatic cells. 
Among FGFs that stimulate somatic cell proliferation of bovine ovarian antral 
follicles, FGF1, FGF2, and FGF7 are mainly produced by TC (Parrott and Skinner, 1998; 
Berisha et al., 2000; Berisha et al., 2004; Buratini et al., 2007), while the major producers of 
FGF9 are GC (Schreiber et al., 2012). FGF1, FGF2, and FGF9 stimulate both GC and TC 
proliferation in either autocrine or paracrine ways (Gospodarowicz et al., 1977b; 
Gospodarowicz et al., 1977c; Gospodarowicz et al., 1985; Spicer and Stewart, 1996; 
Schreiber and Spicer, 2012; Schreiber et al., 2012) whereas FGF7 stimulates GC proliferation 
in a paracrine way (Parrott et al., 1994). 
2.3  Role of fibroblast growth factors in ovarian follicular fate 
Besides stage of folliculogenesis and species, another important factor associated 
with the production of FGFs in antral follicles is follicular health (Buratini et al., 2007; 
Portela et al., 2010). It is now well accepted that antral follicles grow and develop until they 
reach one of two fates: ovulation or atresia, the latter occurring in the vast majority of the 
follicles (Hirshfield, 1988; Chun et al., 1994; Jolly et al., 1994; McGee and Hsueh, 2000). 
Follicular atresia is characterized as a degenerative process associated with apoptosis, 
occurring mainly in GC of many species, including rats (Hughes and Gorospe, 1991; Chun et 
al., 1995) and cattle (Rajakowski, 1960; Jolly et al., 1994; Evans et al., 2004). Ovarian 
follicles in all stages of growth and at any stage of life until the occurrence of reproductive 
senescence are susceptible to undergo atresia (Hughes and Gorospe, 1991). In cattle, an 
increase in the rate of atresia of large antral follicles is observed as the estrous cycle advances 
toward ovulation (Spicer and Echternkamp, 1986). In rats, a dramatic increase in numbers of 
atretic follicles appears just after ovulation (Hirshfield, 1988). Among other features, atretic 
follicles are characterized by pyknosis of the nuclei and fragmentation of DNA in GC, a 
decreased aromatase activity, and thus, estrogen production (Hughes and Gorospe, 1991; 




characterized by TC with LH receptors uncoupled from adenylate cyclase, which are 
incapable of synthesizing steroids in response to LH, resulting in a reduction in theca 
androgen synthesis concomitant with an increased output of progesterone (McNatty et al., 
1985) and TC hypertrophy (Rajakowski, 1960; Bukovsky et al., 1993). Therefore, large antral 
follicles that are selected to escape atresia to become dominant and ovulate have a high 
estrogen to progesterone ratio (Ireland and Roche, 1982; Spicer and Echternkamp, 1986). To 
date, members of the FGF family that appear to be associated with health of large antral 
follicles include FGF1 (Schams et al., 2009), FGF2 (Tilly et al., 1992; Lynch et al., 2000), 
FGF7 (Castilho et al., 2015), FGF8 (Sugiura et al., 2007; Miyoshi et al., 2010), FGF9 
(Schreiber and Spicer, 2012), FGF10 (Buratini et al., 2007), FGF17 (Machado et al., 2009), 
and FGF18 (Portela et al., 2010). Depending on the species, these FGFs can stimulate 
survival or atresia of large follicles and their production change according to health of the 
follicles. 
In cattle, FGF1 and FGF8 appear to be contributing to follicular survival. FGF1 
stimulates bovine GC and TC proliferation (Gospodarowicz et al., 1977b; Gospodarowicz et 
al., 1977c) while polymorphisms of the FGF8 gene were associated with the number of 
oocytes collected by ovum pick up (Santos-Biase et al., 2012), suggesting possible roles for 
this growth factor in follicular development. 
As already mentioned in this review, FGF2, FGF7, FGF9, FGF10, FGF17, and 
FGF18 inhibit steroidogenic enzymes activity and FSH-stimulated estradiol production by 
GC in cattle (Vernon and Spicer, 1994; Parrott and Skinner, 1998; Buratini et al., 2007; 
Machado et al., 2009; Portela et al., 2010; Schreiber and Spicer, 2012; Castilho et al., 2015). 
Because estradiol production is important for GC survival and differentiation of dominant 
follicles (Knecht et al., 1985; Fortune et al., 2004), FGFs suppressing estradiol production 
may be inducing atresia or preventing differentiation of GC in cattle. In agreement with this 
idea is the fact that mRNA abundance for FGF9, FGF10, FGF17, and FGF18 in bovine GC 




2007; Machado et al., 2009; Portela et al., 2010; Schreiber et al., 2012; Castilho et al., 2015). 
As mentioned above, FGF2, FGF7, and FGF9 stimulate bovine GC proliferation (Parrott et 
al., 1994; Spicer and Stewart, 1996; Schreiber and Spicer, 2012), and thus may act as anti-
differentiation factors rather than stimulating follicular atresia in cattle. Although FGF10 does 
not stimulate GC proliferation (Buratini et al., 2007), FGF10 stimulates cumulus expansion 
and glucose uptake by the cumulus-oocyte complex in cattle (Caixeta et al., 2013), indicating 
that it may play a role in oocyte growth, maturation, and ovulation (Zuelke and Bracket, 
1992; Chen et al., 1993; Downs et al., 1996; Sutton-McDowall et al., 2004). On the other 
hand, FGF18 induced regression of the dominant follicle when injected in vivo and increased 
cleaved caspase-3 in GC in vitro (Portela et al., 2015), which is a major downstream effector 
of apoptosis and serves a marker for GC apoptosis (Feranil et al., 2005), confirming the role 
for this protein in induction of atresia in bovine antral follicles. 
In addition to their roles in folliculogenesis of cattle, FGFs have been shown to play 
roles in development of antral follicles of other species. FGF1 and FGF2 mRNA abundance 
is greater in TC of porcine periovulatory follicles (Schams et al., 2009), suggesting a positive 
role of these FGFs in follicular survival in this species. FGF2 seems to stimulate antral 
follicle survival of rats, since it stimulates the production of both estradiol and progesterone 
of rat GC (Yamoto et al., 1993) while inhibiting apoptosis of rat GC (Tilly et al., 1992). FGF8 
appears to be important in antral follicle development in mice, since it acts to stimulate 
glycolysis of mouse cumulus cells, which is important to provide energy to the oocyte 
(Sugiura et al., 2007), but, in rat GC, FGF8 suppressed FSH-induced estradiol production 
(Miyoshi et al., 2010), what could imply a role in atresia in this species. Similarly, FGF9, as 
previously mentioned in this review, has stimulatory effects on steroidogenesis of murine 
(Drummond et al., 2007) and porcine GC (Evans et al., 2014), implying a role in antral 
follicle survival in these species. 




Some FGFs appear also to influence formation and function of the corpus luteum. 
The corpus luteum is a transient endocrine gland in the adult ovary that forms from the 
ruptured follicle after ovulation and secretes progesterone to allow implantation of the early 
embryo in the endometrium and to provide a uterine environment that sustains pregnancy (as 
reviewed by Keyes and Wiltbank, 1988). From the 22 known members of the FGF family, at 
least FGF2, FGF7, FGF9, and/or FGF10 have been detected in corpus luteum of rats 
(Guthridge et al., 1992; Drummond et al., 2007) and cattle (van Wezel et al., 1995; Salli et al., 
1998; Castilho et al., 2008).  
In cattle and sheep, FGF1 seems to be contributing to early development of corpus 
luteum, stimulating luteal cell proliferation (Gospodarowicz et al., 1977b; Grazul-Bilska et 
al., 1995) and progesterone production of ovine luteal cells early (i.e., day 5) in the estrous 
cycle (Grazul-Bilska et al., 1995). Nevertheless, FGF1 may also be involved in luteolysis in 
cattle (Neuvians et al., 2004). 
Similarly, FGF2 stimulates progesterone production by luteal cells from cattle 
(Miyamoto et al., 1992), sheep (Grazul-Bilska et al., 1995), and rats (Tamura et al., 1991). 
FGF2 has also been reported to stimulate angiogenesis (Cross and Claesson-Welsh, 2001; 
Robinson et al., 2008), a prominent characteristic of the corpus luteum formation (Keyes and 
Wiltbank, 1988), being present in vascular cells of early bovine corpus luteum (Schams et al., 
1994) and in cytoplasm of endothelial cells of the capilary bed of theca interna and in larger 
vessels of the theca externa of mature bovine follicles (Berisha et al., 2000). In particular, 
vascular endothelial growth factor A (VEGFA) and FGF2 synergized to increase bovine 
luteal endothelial cell networks (Robinson et al., 2008), and intracellular injections of 
antibodies against either VEGFA or FGF2 markedly reduced corpus luteum volume and 
plasma progesterone concentrations (Yamashita et al., 2008). Therefore, formation and 
regulation of corpus luteum is another feature of FGFs in reproduction of mammals.  




The FGFR is a single chain transmembrane tyrosine kinase with two or three 
immunoglobulin-like domains and a heparin-binding sequence in the extracellular ligand-
binding portion (Ornitz and Itoh, 2001; Itoh and Ornitz, 2004; Li et al., 2016). As previously 
mentioned in this review, there are four distinct genes encoding for FGFRs (FGF1-FGF4) in 
vertebrates and mRNA alternative splicing occurs in the immunoglobulin-like domains III of 
the FGFR1, FGFR2, and FGFR3 genes (but not of FGFR4), generating diversity of sequence 
and resulting in various isoforms (Itoh and Ornitz, 2004; Ornitz and Itoh, 2015; Li et al., 
2016). The ligands of the FGF family have different affinities for these receptors (Itoh and 
Ornitz, 2004), which are determined by the immunoglobulin-like domains (Dell and 
Williams, 1992).  
Because FGFRs have different ligand-binding specificities (see Table 2), the 
localization of FGFRs in the different follicle compartments is of fundamental importance for 
the FGFs to exert their effects on ovarian physiology. Of the ligands in this growth factor 
family that are produced in the ovary, the main receptors, according to ligand binding 
specificity, that would be expected to be present in order for cells to respond to them are: 
FGFR1c and FGFR3c for FGF1 and FGF2; FGFR2b followed by FGFR1b for FGF7, FGF10, 
and FGF22; FGFR3c followed by FGFR4 for FGF8, FGF17, and FGF18; and FGFR3c 
followed by FGFR2c for FGF9 and FGF16 (Ornitz and Itoh, 2015). Evidence clearly shows 
species differences exist in terms of which of these FGFRs exist in ovarian cells. 
In cattle, FGFR1c mRNA, the preferred receptor for FGF1 and FGF2, has been 
detected in oocytes and in cumulus cells, increasing in response to FSH treatment (Zhang and 
Ealy, 2012). In chickens, FGFR1 mRNA and protein are intensely expressed in GC and are 
critical for FGF1-induced GC proliferation (Lin et al., 2012). Therefore, FGFR1c in cattle and 
FGFR1 in chickens seem important for the actions of FGF1 in promoting follicular 
development. In rats, FGFR1 mRNA was detected in ovaries during proestrus, estrus, and 
metestrus, but not during diestrus (Asakai et al., 1994). Interestingly, no FGFR1 




FGFR2b, the main receptor for FGF7, FGF10, and FGF22, is detected in GC and 
oocytes of cattle (Berisha et al., 2004; Buratini et al., 2007; Machado et al., 2009; Zhang and 
Ealy, 2012), while FGFR1b, the second most important receptor for these growth factors, is 
detected in bovine GC, TC, and oocytes (Zhang and Ealy, 2012; Castilho et al., 2015). As 
previously mentioned in this review, FGF7 and FGF10, produced by TC, decrease aromatase 
activity of GC (Parrot and Skinner, 1998; Castilho et al., 2015) and thus appear to play a role 
in anti-differentiation of these cells. Interestingly, FGFR2b and FGFR1b GC mRNA are both 
greater in future subordinate follicles than in future dominant follicles (Castilho et al., 2015), 
and this reinforces the idea that FGFs from this subfamily impede GC to differentiate and 
therefore may regulate follicle selection in cattle. In pigs, a polytocous species, different than 
in cattle, FGFR2b mRNA abundance is greater in TC than in GC, and greater in theca interna 
of large and preovulatory follicles than in those of small and medium follicles (Schams et al., 
2009), suggesting a role for FGF7 and FGF10 in differentiation of TC in this species. 
FGFR2c, the second main receptor for FGF9 and FGF16, has been detected in both 
bovine GC and TC, without changes in final follicular growth in cattle (Berisha et al., 2004). 
Little is currently known about the FGF16 functions in GC and TC, but FGF9, as stated 
earlier in this review, has effects on proliferation and steroidogenesis of both GC and TC in 
different sizes of antral follicles (Schreiber and Spicer, 2012; Schreiber et al., 2012) and may 
therefore rely on this receptor in all moments of folliculogenesis in cattle. In pigs, Schams 
and colleagues (2009) reported a greater FGFR2c mRNA in TC from large follicles with no 
differences for mRNA abundance of this isoform in GC among different sizes of follicles. In 
contrast, in a more recent study, Evans and coauthors (2014) reported a greater GC FGFR2c 
mRNA abundance in large than in small and medium follicles of gilts. Still, taken together, 
these observations imply a role for FGF9 in final maturation of ovarian follicles in pigs, and 
are in agreement with the observation that FGF9 stimulates estradiol production by GC in this 




Bovine FGFR3c, the main receptor for FGF8, FGF9, FGF16, FGF17, and FGF18 was 
detected in both GC and TC, but not in the oocyte, and increased in GC (but not in TC) of 
small healthy follicles and in response to FSH (Buratini et al. 2005a), implying a role for 
these FGFs in early stages of antral follicle development in cattle. In rats, FGFR3 protein 
levels were detected in oocytes, GC, TC, and corpora lutea (Drummond et al., 2007), 
suggesting an important role for ligands such as FGF9, an inducer of rat GC progesterone 
production (Drummond et al., 2007) in folliculogenesis of this species. 
Bovine FGFR4, the second most important receptor for FGF8, FGF17, and FGF18, 
has been detected in TC, but not in GC or oocytes of antral follicles, being greater in small 
than in large follicles (Buratini et al., 2005a). Since FGF17 and FGF18 are apparently 
involved in follicular atresia, it is likely that they would be exerting this role in a receptor that 
is predominant in small antral follicles, since large follicles are being selected for dominance 
and ovulation. In mice, FGFR4 mRNA has been detected in GC, but not in TC or oocytes, 
during most phases of folliculogenesis (Puscheck et al., 1997). In human follicles, FGFR4 
immunostaining was most prevalent in oocytes but also existed in GC and stromal cells (Ben-
Haroush et al., 2005). 
As already mentioned in this review, the intraovarian production of FGFs start early 
in folliculogenesis. So, for these FGFs to have an effect, FGFRs must also need to be present. 
Indeed, mRNA encoding at least four FGFRs has currently been detected in fetal bovine 
preantral follicles, including FGFR1b, FGFR2b, FGFR3c, and FGFR4 (Buratini et al., 2005b; 
Castilho et al., 2014). In addition, in mice, FGFR4 mRNA has been detected in GC of 
primary, secondary, and preantral follicles (Puscheck et al., 1997). Such observations confirm 
the importance of the FGF family in all stages of folliculogenesis in mammals. 
3. Role of other growth factors on ovarian physiology 
In addition to FGFs, aforementioned in this review, other growth factors are critical 




growth factor β family deserve special attention for their contribution in development of 
ovarian follicles.  
3.1 IGF system 
The growth factors IGF-1 and IGF-2 are single-chain polypeptides functionally and 
structurally related to insulin, first isolated from human plasma in the 1970s (Rinderknecht 
and Humbel, 1976; Rinderknecht and Humbel, 1978a; Rinderknecht and Humbel, 1978a; 
Zapf et al., 1984). The IGFs are mainly produced by the liver to be released in the circulation 
in order to stimulate endocrine actions in target cells, but are also locally produced in tissues 
to have a paracrine or autocrine actions (for review, see Sara and Hall, 1990). These actions 
include DNA and protein synthesis (Canalis, 1980; Zapf et al., 1984), cell proliferation 
(Frödin and Gammeltoft, 1994), decreased lipolysis (Zapf et al., 1978), increased glucose 
transport and oxidation (Schwartz and Goodman, 1976; Guler et al., 1987), and increased 
glycogenesis (Froesch et al., 1985; Parkes et al., 1986; Zapf et al., 1986) on various tissues. 
Because of their potent mitogenic effects, IGFs have also been reported in cancer of various 
tissues (Myal et al., 1984; Mattsson et al., 1986; Pollak et al., 1990; Halje et al., 2012). 
For IGFs to exert their actions, they bind to two receptors, type 1 and type 2 IGF 
receptors (IGF-1 receptor and IGF-2 receptor, respectively), in various target tissues (Sara 
and Hall, 1990). The IGF-1 receptor is a glycoprotein consisting of two extracellular α-
subunits linked via disulfide bonds with two transmembranal β-subunits with tyrosine-kinase 
activity, sharing a structural and functional similarity with the insulin receptor (Massagué and 
Czech, 1982; Morgan et al., 1986; LeRoith et al., 1995). The binding of the ligand to the 
extracellular subunits results in intracellular signal transduction by autophosphorylation of 
tyrosine residues within the intracellular subunits (Morgan et al., 1986). Distinct from the 
IGF-1 receptor, the IGF-2 receptor is monomeric and does not have intrinsic tyrosine kinase 
activity, but is phosphorylated on tyrosine residues (Laureys et al., 1988; Schmid, 1995). The 
IGF-1 receptor has a higher affinity for IGF-1 than for IGF-2, and a low affinity for insulin, 




insulin (Massagué and Czech, 1982; Schmid, 1995; Sara and Hall, 1990). Current evidence 
suggests that IGF-2 receptor is acting as a decoy receptor, inactivating IGF-2 in a similar way 
to IGFBPs (Spicer and Aad, 2007; Aad et al., 2013).  
Effects of IGFs in the ovary of various species have been reported more than three 
decades ago (Savion et al., 1981; Baranao and Hammond, 1984). Since then, these 
polypeptides have been described to be important regulators of ovarian follicular cells 
proliferation, steroidogenesis, and selection of dominant follicles in various species (Adashi 
et al., 1991; Spicer and Echternkamp, 1995). In addition, synthesis of IGFs by ovarian 
follicular cells to stimulate autocrine and paracrine actions is under regulation of various 
hormones (Spicer and Echternkamp, 1995).  
The roles of IGFs start early in folliculogenesis with mRNA expression for IGFs and 
IGF receptors being detected in different stages of preantral follicle development (Silva et al., 
2009). In goats, IGF-1 and IGF-2 stimulated early antrum formation and oocyte growth, 
survival, and competence of prentral follicles (Zhou and Zhang, 2005; Magalhães-Padilha et 
al., 2012; Duarte et al., 2013). In mice, IGF-1 stimulated oocyte competence of preantral 
follicles in vitro (Jee et al., 2012). In buffalo, expression of IGF-2 and IGF receptors was 
detected in oocyte, GC, and TC of preantral follicles (Dubey et al., 2015). In primates, in vitro 
androgen increased IGF receptors in the oocytes of primordial follicles and increased the 
number of primary follicles, suggesting that the IGF system may be important for primordial 
follicle entry into the growth pool (Vendola et al., 1999). In humans, IGF-1 and IGF-1 
receptor mRNA and protein have been detected in preantral follicles and IGF-1 stimulated 
initiation of preantral follicle growth (Stubbs et al., 2013). In cattle, IGF-1 receptor mRNA 
was detected in oocytes, GC and TC of preantral follicles, suggesting a role for the IGF 
system in early folliculogenesis (Amstrong et al., 2000; Amstrong et al., 2002). 
In bovine antral follicles, IGF-1 mRNA has been mainly detected in GC and IGF-2 




2002) while IGF-1 receptor mRNA has been detected in GC, TC, and oocytes (Schams et al., 
2002; Armstrong et al., 2002) and IGF-2 receptor mRNA has been detected in GC and TC 
(Spicer and Aad, 2007; Aad et al., 2013). Because IGF-2 has a greater expression than IGF-1 
in the bovine ovary (Armstrong et al., 2000), it is currently believed that IGF-2 is the main 
intrafollicular IGF ligand, performing paracrine and autocrine actions while most of IGF-1 
comes from the liver to elicit endocrine effects in this species (Velazquez et al., 2008). In rats, 
IGF-1 mRNA is expressed in GC, but not in TC whereas IGF-2 mRNA is present in TC but 
not GC (Oliver et al., 1989; Hernandez, 1995). In human small antral follicles, IGF-1 and 
IGF-2 mRNA detection was restricted to TC while IGF-1 receptor mRNA was detected 
exclusively in GC and IGF-2 receptor was detected in both GC and TC; in dominant follicles, 
no IGF-1 mRNA has been detected, IGF-2 mRNA has been detected exclusively in GC, IGF-
1 receptor mRNA has been detected in GC, and IGF-2 receptor has been detected in both TC 
and GC (el-Roeiy et al., 1993). In porcine antral follicles, IGF-1 mRNA has been detected in 
GC while IGF-2 mRNA has been detected in TC (Hammond et al., 1985; Yuan et al., 1996). 
Ovarian synthesis of IGFs and their receptors is under hormonal regulation. In cattle, 
FSH, LH, cortisol, insulin, and growth hormone (GH) alone and epidermal growth factor 
(EGF) or FGF2 together with insulin all decrease GC IGF-1 secretion in vitro (Spicer et al., 
1993; Spicer and Chamberlain, 2000) while cortisol and tumor necrosis factor α (TNFα) 
decreased IGF-1 receptor synthesis by TC (Spicer and Chamberlain, 1998; Spicer, 2001). In 
rats, whole ovarian IGF-1 synthesis was decreased by FSH and increased by estrogen, IGF-2 
production was decreased by estrogen, and IGF-1 receptor synthesis was increased by FSH 
(Hernandez, 1995; Zhou et al., 2013). In pigs, GH, FSH, and estradiol all increased GC IGF-1 
secretion in vitro (Hsu and Hammond, 1987). In humans, FSH stimulates IGF-2 gene 
expression by GC (Baumgarten et al., 2015). 
Mitogenic effects of IGFs in ovarian follicular cells are well established. Both ligands 
bind to IGF-1 receptors to stimulate cell proliferation (Schmid, 1995; Spicer and Aad, 2007). 




1993; Stewart et al., 1995; Gutiérrez et al., 1997), pigs (Baranao and Hammond, 1984; May et 
al., 1988; May et al., 1992; Kolodziejczyk et al., 2003), and rats (Bley et al., 1992; Duleba et 
al., 1997; Duleba et al., 1999), and also stimulates proliferation of GC from sheep (Monniaux 
and Pisselet, 1992), and humans (Bergh et al., 1991; Yong et al., 1992). IGF-2 stimulates 
proliferation of GC of cattle (Spicer and Aad, 2007), humans (Di Blasio et al., 1994; 
Baumgarten et al., 2015), pigs (Baranao and Hammond, 1984), and rats (Adashi et al., 1985; 
Duleba et al., 1997). 
Effects of IGFs in ovarian steroidogenesis have been extensively studied. In several 
mammalian species, these polypeptides have been described to amplify gonadotropins effects, 
stimulating steroidogenesis and steroidogenic enzymes in presence of FSH and LH (Adashi et 
al., 1991; Spicer and Echternkamp, 1995; Armstrong et al., 1996). In fact, IGF-1 is required 
for effects of FSH on the steroidogenis through the AKT signaling pathway in humans, mice, 
and rats GC (Zhou et al., 2013). In cattle, IGF-1 has been reported to enhance FSH-stimulated 
estradiol and LH-stimulated progesterone production by GC, also enhancing the expression of 
steroidogenic enzymes such as aromatase (Schams et al., 1988; Spicer et al., 1993; Gutiérrez 
et al., 1997; Spicer and Chamberlain, 1998; Spicer, 2001; Spicer and Aad, 2007), and to 
increase LH-stimulated progesterone and androstenedione production by TC (Stewart et al., 
1995; Spicer and Chamberlain, 1998; Spicer, 2001). In pigs, IGF-1 enhances FSH-stimulated 
estradiol and progesterone production by GC (Baranao and Hammond, 1984; Kolodziejczyk 
et al., 2003; Ranzenigo et al., 2008). In rats, IGF-1 increases the FSH-supported estradiol and 
progesterone biosynthesis by GC, the FSH-mediated acquisition of LH receptors by GC, and 
the LH-stimulated progesterone by TC (Adashi et al., 1986; Adashi et al., 1991; Duleba et al., 
1999; Zhou et al., 2013). In humans and sheep, IGF-1 also has a stimulatory effect in FSH-
stimulated estradiol production (Bergh et al., 1991; Armstrong et al., 1996). Similar to IGF-1, 
IGF-2 enhances FSH-stimulated estradiol and progesterone biosynthesis and aromatase 
expression in bovine GC (Spicer and Aad, 2007), FSH-stimulated estradiol and progesterone 




progesterone production by porcine GC (Baranao and Hammond, 1984). These steroidogenic 
effects of IGF-2 are believed to be performed through the IGF-1 receptor (Spicer and Aad, 
2007). Recently, it was suggested that changes in IGF-2 receptor abundance in GC may 
regulate ovulation rate in cattle (Aad et al., 2012). 
Because of their stimulatory effects on steroidogenesis, IGFs are considered 
important for follicular selection for dominance in monotocous species such as cattle (Spicer, 
2004; Fortune et al., 2004). Although, there are no differences in total IGF intrafollicular 
concentrations between dominant and subordinate follicles in cattle (Stewart et al., 1996), 
levels of insulin-like binding proteins (IGFBPs) change during follicular development in 
various species, including sheep and cattle (Monget et al., 1993; Spicer at al., 2001). The 
IGFBPs are important for storage and transportation of IGFs through circulation, being 
important regulators of the IGFs physiological action (Sara and Hall, 1990; Murphy, 1998). In 
the ovary, six IGFBPs (IGFBP-1 to IGFBP-6) have been identified in antral follicles of 
mammals (for reviews, see Spicer and Echternkamp, 1995; Fortune et al., 2004; Spicer, 
2004). In cattle, the major forms of IFBPs produced by GC are IGFBP-2, IGFBP-5, and 
IGFBP-4 while the major forms produced by TC are IGFBP-3, IGFBP-2, IGFBP-5, and 
IGFBP-4 (Chamberlain and Spicer, 2001); in sheep, the major forms produced by GC are 
IGFBP-2, IGFBP-5, and IGFBP-1 while TC produces mainly IGFBP-4 and IGFBP-2 
(Armstrong et al., 1996); in pigs, GC produce IGFBP -2 to -6 (Leighton et al., 1993). Some 
IGFBPs, specifically the low molecular weight IGFBP -2, -4, and -5 are increased in atretic 
follicles of sheep (Monget et al., 1993), cattle (de la Sota et al., 1996; Stewart et al., 1996; 
Spicer et al., 2001; Rivera and Fortune, 2003), mice (Wandji et al., 1998), and humans (San 
Roman and Magoffin, 1993; Wright et al., 2002). Moreover, IGFBP -2, -3, -4, and -5 and 
have inhibitory effects on IGF-stimulated steroidogenesis, binding IGFs and preventing them 
to bind to their receptors (Ui et al., 1989; Bicsak et al., 1990; Spicer and Chamberlain, 1999; 
Wright et al., 2002). Therefore, for follicular dominance to occur, levels of low molecular 




pregnancy-associated plasma protein A (Spicer et al., 2001; Rivera et al., 2001; Rivera and 
Fortune, 2003; Spicer, 2004). 
In summary, the ovarian IGF system (IGF ligands, receptors, and binding proteins) is 
critical for follicular development and selection for dominance through mitogenic and 
steroidogenic activity. The bioavailability of IGF ligands, especially IGF-1, is more important 
than their total concentrations and levels of IGBPs are therefore suppressed in dominant 
follicles by specific proteases.  
 
3.2 Transforming growth factor β family 
The TGF-β superfamily is a large group of more than 35 polypeptides in vertebrates 
that regulate many aspects of cell proliferation and organogenesis, including development of 
gonads, heart, bones, and blood vessels. Members of this superfamily include TGF-βs, bone 
morphogenic proteins (BMPs), growth differentiation factors (GDFs), anti-Müllerian 
hormone (AMH), activins, and inhibins (for review, see Chang et al., 2002). 
Members of the TGF-β superfamily possess homo- or hetero-dimers that bind to and 
activate two types of transmembrane serine/threonine kinase receptors, which then stimulate 
downstream regulatory SMAD proteins to migrate from the cytoplasm to the nucleus where 
they can act as transcriptional regulators. Activins and TGF-βs typically use different signal 
transduction pathways than BMPs. Activins and TGF-βs will first bind receptor type II, which 
will then recruit and phosphorylate receptor type I, which will in turn phosphorylate SMAD2 
or SMAD3, allowing each to migrate to the nucleus and interact with SMAD4 and 
transcription factors to stimulate specific target genes; BMPs will bind to either type I or type 
II receptor to stimulate formation of a quaternary complex and then type I receptor will be 
phosphorylated by type II and will phosphorylate SMAD1, SMAD5, or SMAD8, allowing 
each to translocate to the nucleus to interact with SMAD4 and transcription factors in order to 




Many TGF-β superfamily members have been detected in the mammalian ovary, 
including TGF-α, TGF- β, inhibin, activin, follistatin, BMP-2, BMP-3, BMP-4, BMP-6, 
BMP-7, GDF-9, BMP-15, AMH (for reviews, see Ying, 1988; Knight and Glister, 2001; 
Durlinger et al., 2002a; Shimazaki et al., 2004; Drummond, 2005; Skinner, 2005; Mazerbourg 
and Hsueh, 2006). These polypeptides regulate folliculogenesis of various species through 
paracrine, autocrine, and endocrine actions, playing roles in ovarian steroidogenesis (Ying et 
al., 1986; Miró et al., 1991; Shukovski et al., 1991; Shimasaki et al., 1999; Campbell et al., 
2012), follicular cell proliferation (Roberts and Skinner, 1991; Glister et al., 2004; Spicer et 
al., 2008; Kayani et al., 2009), and oocyte maturation (Alak et al., 1998). 
3.2.1 Role of TGF-α and TGF- β on folliculogenesis 
The 50 amino acid polypeptide TGF-α is structurally similar to epidermal growth 
factor (EGF) and able to bind to EGF receptors to elicit its effects in a variety of cells, 
including skin keratinocytes and epithelial cells in the brain, pituitary, and various embryonic 
tissues (Brachmann et al., 1989). In the ovary, TGF-α mRNA has been detected in rat GC 
(Yeh et al., 1993), in bovine TC (Skinner and Coffey, 1988; Lobb and Dorrington, 1992), in 
human TC (Lobb, 2009), and mainly in porcine GC, although small amounts were also 
detected in porcine TC (Singh and Armstrong, 1995). 
The TGF-β polypeptide is a dimer of 112-amino acid subunits linked by disulfide 
bonds. In mammals, the family of TGF-β consists of at least four closely related isoforms: 
TGF-β1 (commonly referred as simply “TGF-β”), TGF-β2, TGF-β3, and TGF-β4 (for review, 
see Lyons and Moses, 1990). In the ovary of cattle, TGF-β1 has been detected in oocytes and 
GC while TGF-β2 and TGF-β3 have been detected in oocytes, GC, and TC with a stronger 
intensity than TGF-β1 in preantral and antral follicles (Nilsson et al., 2003). In sheep, TGF-β1 
and TGF-β2 are restricted to TC (Juengel et al., 2004) and in humans, TGF-β1 has been 
detected in GC and TC of antral follicles (Lobb, 2009). In pigs, TC are the main source of 




(Kim and Schomberg, 1989; Teerds and Dorrington, 1992), TC (Teerds and Dorrington, 
1992), and oocytes (Teerds and Dorrington, 1992; Ergin et al., 2008), but the amounts of 
TGF-β1 are always greater than TGF-β2 in these cells (Teerds and Dorrington, 1992). 
Although recognized for their mitotic effects in many tissues, TGFs have different 
actions in ovarian follicular cell proliferation according to the species. In cattle, TGFs have 
contrasting effects on GC proliferation: while TGF-α stimulates proliferation of GC, TGF-β 
inhibits GC proliferation by paracrine and autocrine actions (Lobb and Dorrington, 1992). In 
rats, TGF-β stimulates GC proliferation (Saragüeta et al., 2002) whereas both TGF-α and 
TGF-β increase TC proliferation (Pehlivan et al., 2001). In pigs, TGF-β has been described to 
inhibit EGF-stimulated GC proliferation, although the opposite has also been observed under 
diverse experimental circumstances (May et al., 1988; Mondschein et al., 1988). In humans, 
TGF-α stimulates, while TGF-β1 inhibits, GC from small antral follicles (Lobb, 2009). 
The effects of TGF-α and TGF-β on steroidogenesis also vary according to the 
species. In cattle, TGF-α suppresses FSH-stimulated estradiol production by GC while both 
TGF-α and TGF-β suppress estradiol-stimulated progesterone production by TC (Roberts and 
Skinner, 1991; Legault et al., 1999) and EGF inhibited insulin-induced progesterone and 
androstenedione production by TC (Spicer and Stewart, 1996). Nevertheless, in the presence 
of estradiol, TGF-β increases progesterone production by TC, suggesting a distinct role for 
this polypeptide according to the stage of follicle development in cattle (Roberts and Skinner, 
1991). In rats, both TGF-α and TGF-β enhance FSH-stimulated progesterone synthesis by GC 
(Yeh et al., 1993; Ke et al., 2004; Chen et al., 2008). In pigs, TGF-α stimulates estradiol 
production by GC from prepubertal females (Gangrade et al., 1991) whereas TGF-β inhibits 
FSH-induced progesterone production by porcine GC (Mondschein et al., 1988). In sheep, 
TGF-β suppresses progesterone production by GC (Juengel et al., 2004). 




Activins and inhibins are disulphide-linked dimeric glycoproteins: while inhibins are 
dimers of a α subunit linked to either a α A or a α B subunit to generate inhibin A (α-βA) or 
inhibin B (β-βB), activins are a result of dimerization of β subunits, which results in three 
forms of activin known as activin A (βA-βA), activin AB (βA-βB) and activin B (βB-βB). 
Follistatins are single chain glycosylated polypeptides rich in cysteine that bind to and 
suppress the effects of activin (for reviews, see Ying, 1988; Knight and Glister, 2001). 
The first recognized role for activins, inhibins, and follistatin in reproduction was 
their ability to modulate the secretion of FSH from anterior pituitary gonadotropins in vitro. 
More specifically, inhibins and follistatin suppress FSH secretion while activins enhance FSH 
secretion (for reviews, see Ying, 1988; de Kretser and Robertson, 1989; Knight and Glister, 
2001). In the 1980s, several groups isolated inhibins, activins, and follistatin from follicular 
fluid (Robertson et al., 1985; Ling et al., 1986; Ueno et al., 1987) and ovaries of farm animals 
(Henderson and Franchimont, 1981; Michel et al., 1989).  
In the ovary of cattle, inhibins have been detected in mainly in GC, but also in TC 
(Henderson and Franchimont, 1981; Torney et al., 1989; Izadyar et al., 1998), activins have 
been detected in GC (Izadyar et al., 1998), and follistatin has been detected in GC and 
oocytes (Izadyar et al., 1998). In rats, inhibins have been detected in GC, TC, and oocytes 
(Erickson and Hsueh, 1978; Suzuki et al., 1987; Meunier et al., 1988; Ogawa et al., 1991), 
and activins and follistatin have been detected mainly in GC (Meunier, 1988; Kogawa et al., 
1991; Nakatani et al., 1991), and follistatin has been detected in GC (Kogawa et al., 1991). In 
pigs, inhibins and follistatin have been detected in GC (Michel et al., 1989; Lindsell et al., 
1995), and activins have been detected in in GC and TC (Van Den Hurk and Van De Pavert, 
2001). In humans, inhibins have been detected in GC (Channing et al., 1984; Yamoto et al., 
1992; Erämaa et al., 1995; Sidis et al., 1998), activins have been detected in GC (Sidis et al., 





Activins, inhibins, and follistatin play a distinct role in folliculogenesis of different 
species. In cattle, while activins have a suppressive effect on LH-stimulated progesterone 
production by GC and TC from antral follicles, follistatin increased LH-stimulated 
progesterone production on the same cell types (Shukovski et al., 1991; Shukovski et al., 
1993), indicating that the actions of activin should be suppressed as the follicle approaches 
luteinization. In addition, inhibins suppress estradiol production by bovine GC (Jimenez-
Krassel et al., 2003), showing an anti-differentiation action. In rats, activins act to increase 
responsiveness of GC to FSH, increasing FSH receptor concentrations, aromatase expression, 
progesterone secretion, estradiol production, and GC proliferation (Xiao et al., 1992; Li et al., 
1995; Miró and Hiller, 1996) while follistatin suppresses activin-stimulated GC proliferation 
(Li et al., 1995) and inhibin increases proliferation of GC (Woodruff et al., 1990). In pigs, 
activin inhibits FSH-stimulated estradiol and progesterone synthesis (Chang et al., 1996). In 
humans, activin stimulates GC proliferation (Rabinovici et al., 1990), but inhibits FSH-
stimulated estradiol and progesterone by GC while inhibin enhances FSH-stimulated estradiol 
production by GC and LH-stimulated progesterone production by TC (Alak et al., 1998; 
Gilling-Simth et al., 1997), and follistatin suppresses activin inhibitory effect on FSH-
stimulated estradiol and progesterone synthesis by GC (Cataldo et al., 1994). 
3.2.3 Role of oocyte-derived GDF-9, BMP-6, and BMP-15 on folliculogenesis 
The communication between oocyte and surrounding somatic cells (GC and TC) is 
critical for folliculogenesis and it has been suggested that the oocyte carries this conversation 
(Matzuk et al., 2002). Among the members of the TGF-β superfamily that regulate ovarian 
folliculogenesis, GDF-9, BMP-15, and BMP-6 are produced mainly by oocytes (for review, 
see Elvin et al., 2000). Indeed, GDF-9 mRNA and protein have been detected in the oocyte of 
primary, secondary and preantral follicles of rat (Hayashi et al., 1999; Jaatinen et al., 1999), 
in oocytes of human primary follicles (Aaltonen et al., 1999), in oocytes of mice at all stages 
of follicular development, except in primordial follicles (McGrath et al., 1995; Dube et al., 




development (Bodensteiner et al., 1999; Spicer et al., 2008). BMP-15, which is structurally 
related to GDF-9, has a similar localization to GDF-9 in rats (Jaatinen et al., 1999), mice 
(Dube et al., 1998), and humans (Aaltonen et al., 1999), but has also been detected in oocytes 
and GC of antral follicles of rats (Erickson and Shimasaki, 2003) and exclusively in oocytes 
of bovine antral follicles (Pennetier et al., 2004). BMP-6 has been detected in oocytes of mice 
(Lyons et al., 1989) and in TC, GC, and oocytes from antral follicles of cattle (Glister et al., 
2004; Kayani et al., 2009). 
Knockout mice models indicate a greater importance for GDF-9 to fertility in 
comparison to BMP-15 and BMP-6, at least in the murine species: while GDF-9 knockout 
female mice are completely infertile and have no follicular development beyond the primary 
one layer follicle stage (Dong et al., 1996), BMP-15 deficient female mice are only subfertile, 
having reduced ovulation and defects in early follicle development (Yan et al., 2001), and 
BMP-6 deficient female mice are fertile (Solloway et al., 1998). Observations that GDF-9 
deficient female mice have a limited oocyte development and have an impaired attachment of 
cumulus cells to the zona pelucida of oocytes may explain why this factor is critical in the 
early stages of follicular development (Carabatsos et al., 1998), since the communication 
between the oocyte and surrounding somatic cells is not working properly in this case. In 
addition, a recent study revealed that GDF9-induced Indian hedgehog homolog (IHH) 
production by GC is needed for TC development (Liu et al., 2015). Moreover, in later stages 
of folliculogenesis, GDF-9 stimulates progesterone production and the expression of enzymes 
involved in cumulus expansion by mice GC (Elvin et al., 1999). 
In rats, GDF-9 promotes follicular survival and growth during the preantral to early 
antral transition, increasing estradiol and testosterone production by GC and therefore 
suppressing GC apoptosis and follicular atresia (Hayashi et al., 1999; Orisaka et al., 2006; 
Orisaka et al., 2009). In later stages, GDF-9 stimulates GC proliferation while it suppresses 
FSH-stimulated estradiol and progesterone production by GC from small antral follicles and 




BMP-15 also stimulates proliferation of GC from rat antral follicles while it suppresses FSH-
stimulated progesterone production with no effects on FSH-stimulated estradiol (Otsuka et 
al., 2000; Otsuka et al., 2001a; Otsuka and Shimasaki, 2002), therefore acting as an anti-
differentiation factor. Different than GDF-9 and BMP-15, BMP-6 does not stimulate 
mitogenic activity of rat GC, but acts like BMP-15 on steroidogenesis of GC, suppressing 
FSH-stimulated progesterone production without affecting estradiol production (Otsuka et al., 
2001b).  
In cattle, GDF-9 acts on TC from antral follicles, enhancing LH-stimulated TC 
proliferation in small follicles, but suppressing LH-stimulated TC proliferation in large 
follicles in the presence of IGF-1 (Spicer et al., 2008). Also, GDF-9 suppresses IGF-1 
stimulation of both androstenedione and progesterone by TC from all sizes of antral follicles 
(Spicer et al., 2008). Similarly, GDF-9 stimulates proliferation of GC but inhibits IGF-1-
induced steroidogenesis of GC from both small and large follicles of cattle (Spicer et al., 
2006). These studies suggest that GDF-9 is acting as an anti-differentiation factor in cattle. 
On the other hand, when added to in vitro maturation medium of bovine cumulus-oocyte 
complexes, BMP-15 enhanced cumulus expansion, which is important for oocyte competence 
(Caixeta et al., 2013). Finally, oocyte-derived BMP-6 stimulates GC proliferation and 
estradiol production while suppressing progesterone production by both GC and TC from 
small bovine antral follicles (Glister et al., 2004; Kayani et al., 2009), thereby stimulating 
follicular survival. 
3.2.4 Role of BMPs on folliculogenesis 
In addition to BMPs derived from oocyte, BMP-2, BMP-3, BMP-4, and BMP-7 may 
also regulate the ovarian follicular development of mammals. These polypeptides regulate 
folliculogenesis of several species through modulation of steroidogenesis and mitosis of 
follicular ovarian somatic cells (for review, see Shimasaki et al., 2004). Among the BMPs 




and rats (Erickson and Shimasaki, 2003), and in oocytes of pigs (Brankin et al., 2005a; 
Paradis et al., 2009). BMP-3 has been detected in TC of rats (Erickson and Shimasaki, 2003) 
and in GC of humans (Jaatinen et al., 1996) whereas BMP-4 has been detected in TC of cattle 
(Glister et al., 2004; Kayani et al., 2009) and rats (Shimasaki et al., 1999; Erickson and 
Shimasaki, 2003), and in the oocyte and GC of pigs (Zhu et al., 2008). BMP-7 has been 
detected in TC of cattle (Glister et al., 2004; Kayani et al., 2009) and rats (Shimasaki et al., 
1999; Erickson and Shimazaki, 2003). 
In cattle, BMP-2 functions as an autocrine factor during follicular dominance and 
ovulation in cattle, because it simulates estradiol production by GC and its expression in GC 
increases as antral follicles grow (Selvaraju et al., 2013). In pigs, BMP-2 suppresses 
progesterone production by GC and TC without affecting GC or TC proliferation (Brankin et 
al., 2005a; Brankin et al., 2005b). 
Theca-derived BMP-4 and BMP-7 may also alter follicular development by 
increasing GC proliferation and modulating steroidogenesis. In rats, BMP-4 and BMP-7 
increased FSH-stimulated estradiol production while suppressing FSH-stimulated 
progesterone production by GC (Shimasaki et al., 1999; Lee et al., 2001; Inagaki et al., 2009). 
Also in rats, BMP-4 promotes the primordial-to-primary follicle transition in neonatal rat 
ovaries (Nilsson and Skinner, 2003). In cattle, BMP-4 and BMP-7 inhibit steroidogenesis in 
GC (Glister et al., 2004; Spicer et al., 2006; Yamashita et al., 2011) and TC (Glister et al., 
2005; Spicer et al., 2008). In humans, BMP-4 and BMP-7 appear to play a role in atresia, 
since both polypeptides decrease gap junction intercellular communication activity (Chang et 
al., 2013) while BMP-4 decreases basal estradiol production by GC (Khalaf et al., 2013). 
3.2.5 Role of AMH on folliculogenesis 
During fetal development, AMH, also called Müllerian inhibiting substance (MIS), is 
produced only by Sertoli cells, but ovarian follicles also produce this polypeptide after birth 




AMH in various species is GC: in cattle, AMH mRNA is expressed in GC of healthy antral 
follicles (Ireland et al., 2009), and in sheep, AMH mRNA is expressed exclusively in GC 
from secondary and antral follicles, decreasing as the follicles grow (Campbell et al., 2012). 
In mice, AMH protein has been detected in primary and early secondary follicles (Durlinger 
et al., 2002b), and in rats, AMH mRNA is expressed in GC from preantral and small antral 
follicles (Baarends et al., 1995). In humans, AMH protein has been detected in secondary, 
preantral, and small antral follicles (Weenen et al., 2004), and may be a valuable indicator of 
ovarian reserve in human assisted reproduction (La Marca et al., 2010; Tolikas et al., 2011). 
In cattle, AMH is a biomarker for fertility, since GC from cows with high numbers of 
antral follicles per ovary have a greater AMH expression than those with numbers of antral 
follicles per ovary (Ireland et al., 2009), and abundance of GC AMH mRNA is greater in 
healthy than in atretic follicles (Rico et al., 2009). In contrast, knockdown of AMH 
bioactivity stimulates development of ovine antral follicles, suggesting an inhibitory role for 
AMH in modulating the response of both TC and GC to gonadotropins in sheep (Campbell et 
al., 2012). Furthermore, AMH suppresses FSH-stimulated estradiol production by GC in 
sheep (Campbell et al., 2012). In mice, AMH reduces numbers of growing primordial 
follicles (Durlinger et al., 2002) and reduces follicular diameter of preantral follicles in vitro 
(Durlinger et al., 2001), suggesting a negative regulation of folliculogenesis in this species. In 
humans, AMH reduces development of primordial follicles (Carlsoon et al., 2006). 
4. Bioinformatics tools for microarray analysis 
With the advent of the genome projects, our knowledge of the genomic sequences of 
humans and other organisms greatly increased (Quackenbush, 2001). Subsequently, a 
diversity of techniques has been developed to investigate the increasing body of information 
provided by the knowledge of the genome (Quackenbush, 2001). One of these techniques is 
cDNA microarray, which allows rapid quantification of expression levels of several genes in 




The technology of cDNA microarray consists of reversing mRNA into cDNA labeled 
with fluorescent nucleotides, which then gets hybridized to a microarray under a glass cover 
slip and scanned for fluorescein emission following laser excitation (Schena et al., 1995; 
Schena, 1996). Differential expression measurements are carried out using a simultaneous, 
two-color hybridization approach of two biological samples of interest, which are mixed and 
hybridized to a single microarray for posterior scanning at two wave-lengths following 
independent excitation of the two fluors (Schena et al., 1995; Schena, 1996). Measurement of 
fluorescence intensity through scanning allows quantification of gene expression and, 
therefore, the direct comparison of gene expression levels between the samples (Schena et al., 
1995; Schena, 1996; Quackenbush, 2001). 
Identifying the various patterns in which a gene is expressed in a microarray and 
grouping genes into expression clusters provide clues into their biological function (Schena et 
al., 1995; Quackenbush, 2001). Nevertheless, interpretation of microarray expression data is 
not an exact science and can be quite challenging (Bowtell, 1999; Quackenbush, 2001; Khatri 
and Draghici, 2005; Huang et al., 2009; Henderson-MacLennan et al., 2010). Therefore, 
bioinformatics tools have becoming increasingly important as the technology for microarray-
based genomic profiling has been progressing (Eisen et al., 1988; Bowtell, 1999; 
Subramanian et al., 2005; Capriotti et al., 2012).  
Over the last few decades, bioinformatics approaches made it possible to find genes 
of pertinent biological functions among large lists of genes (Huang et al., 2009; Capriotti et 
al., 2012). In order to help researchers to find genes of interest in large lists, various high-
throughput enrichment tools, including Onto-Express, GoMiner, and Database for 
Annotation, Visualization, and Integrated Discovery (DAVID), among many others, were 
developed (Khatri and Draghici, 2005; Huang et al., 2009). These bioinformatics enrichment 
tools identify groups of genes that share common biological function, chromosomal location, 
or regulatory elements (Subramanian et al., 2005; Huang et al., 2009). The theory behind this 




chromosomal location (based on prior knowledge), should have an enriched potential as a 
relevant group by the high-throughput screening technologies (Subramanian et al., 2005; 
Huang et al., 2009). Therefore, instead of just comparing individual genes that were up- or 
down- regulated by a treatment or condition, bioinformatics enrichment tools give the 
researcher an opportunity to visualize how genes are being affected in a more global and 
logical manner. 
The importance of enrichment tools such as DAVID can be observed in microarray 
research using Affymetrix gene chips to unveil altered biological functions in response to a 
pathological condition or a hormonal treatment, categorizing clusters of differentially 
expressed transcripts. For example, in farm animals, DAVID was used for identifying 
biological functions altered by IGF-1 treatment in cultured porcine GC (Grado-Ahuir et al., 
2009) or to detect functional differences between bovine GC extracted from healthy or cystic 
antral follicles (Grado-Ahuir et al., 2009), providing valuable data to improve reproductive 
efficiency in pigs and cattle. Moreover, DAVID can be used to investigate biological 
functions altered by pathologies such as human prostatic cancer (Rowehl et al., 2008) or 
diabetic nephropathy (Cohen et al., 2008), providing a better understanding of causes and 
consequences of human diseases and contributing to a possible improvement in therapy 
efficiency. 
Other valuable bioinformatics tool for the interpretation and management of large-
scale genetic data sets is the pathway analysis software. Since biological processes commonly 
involve more than one pathway, this tool identifies networks of pathways altered by a 
treatment, biological condition, or different time points, allowing identification of biological 
functions and canonical signaling pathways, determining the enrichment of differentially 
expressed genes within groups of interconnected pathways and contributing to provide 
meaning to identified differences in gene expression (Werner, 2008; Henderson-MacLennan 




GeneGo, BioBase, Genomatix, and Pathway Studio (Werner, 2008; Henderson-MacLennan et 
al., 2010). 
The web-based pathway analysis software IPA facilitates a meaningful interpretation 
of data by allowing the identification of canonical pathways, mechanistic networks, upstream 
regulators, and downstream biological functions affected by diseases, treatments, or different 
time points (Krämer et al., 2013). Examples of the use of this software include the 
investigation of bovine ovarian follicular activation (Yang and Fortune, 2015), bovine oocyte 
maturation (Mamo et al., 2011), differences between ovarian follicular somatic cells 
(Hatzirodos et al., 2014a; 2014b) of healthy or atretic bovine antral follicles, and differences 
between microRNAs expression pattern in bovine GC of dominant or subordinate follicles 
(Wondim et al., 2014), which shows how the use of this bioinformatics tool has been 
emerging to help researchers to understand biological processes such as ovarian 
folliculogenesis. 









Table 1. Characterization of FGFs subfamilies and their secretion from the 
cells.  
FGF Subfamily Signal peptide and secretion 
FGF 1/ 2 Lack cleavable signal peptide, but are still secreted through non-
conventional mechanisms 
FGF 3/7/10/22 Have N-terminal signal peptide and are secreted through classical 
mechanisms  
FGF 4/5/6 Have N-terminal signal peptide and are secreted through classical 
mechanisms 
FGF 8/17/18 Have N-terminal signal peptide and are secreted through classical 
mechanisms 
FGF 9/16/20 Lack cleavable signal peptide, but are still secreted through non-
conventional mechanisms 
FGF 11/12/13/14 Lack signal peptide and remain inside the cell 
FGF 15/19/21/23 Have N-terminal signal peptide and are secreted through classical 
mechanisms 
	  























Table 2. Receptor affinities for different FGFs subfamilies. 
	  
FGF Subfamily Receptor affinity 
FGF 1/ 2 FGFR 1c, 3c > 2c, 1b, 4 
FGF 3/7/10/22 FGFR 2b > 1b 
FGF 4/5/6 FGFR 1c, 2c > 3c, 4 
FGF 8/17/18 FGFR 3c > 4 > 2c > 1c > 3b 
FGF 9/16/20 FGFR 3c > 2c > 1c, 3b > 4 




FGFR 1c, 2c, 3c, 4 
FGFR 1c, 3c 
FGFR 1c, 3c, 4 
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CHANGES IN FIBROBLAST GROWTH FACTOR 9 (FGF9) mRNA IN 
GRANULOSA AND THECA CELLS DURING OVARIAN FOLLICULAR 
GROWTH IN DAIRY CATTLE 
 
1. Abstract 
Fibroblast growth factor 9 (FGF9) has been suggested to act as an anti-differentiation 
factor in cattle by reducing steroidogenesis and increasing cell proliferation in granulosa (GC) 
and theca (TC) cells. The objective of this study was to characterize FGF9 mRNA abundance 
in GC and TC during development of dominant follicles in dairy cattle. Estrous cycles of non-
lactating dairy cattle were synchronized, and ovaries were collected on either day 3-4 (n = 8) 
or day 5-6 (n = 8) post-ovulation for GC and TC mRNA extraction from small (1-5 mm), 
medium (5.1-8 mm) or large (8.1-18 mm) follicles for PCR analysis. FGF9 mRNA 
abundance was greater (P < 0.05) in GC than in TC. In GC, FGF9 mRNA abundance was 
greater (P < 0.05) in small, medium and large estrogen (E2)-inactive (i.e., concentrations of 
E2 < progesterone, P4) follicles than in large E2-active (i.e., concentrations of E2 > P4) 
follicles at both early (day 3-4) and late (day 5-6) growing phases of first dominant follicle. 
Abundance of FGF9 mRNA was greater (P < 0.05) in medium-sized follicles on day 5-6 than 
on day 3-4 post-ovulation. In TC, FGF9 mRNA abundance was greater (P < 0.05) in large 
E2-inactive follicles than in large E2-active follicles on day 3-4 post-ovulation; no significant 
differences in TC FGF9 mRNA existed among follicle types on day 5-6 post-ovulation. 
Correlations among levels of hormones and FGF9 mRNA levels revealed significant negative 
correlations between GC FGF9 mRNA abundance and follicular fluid E2 (r = -0.68), E2/P4 




FGF9 mRNA in GC and TC is greater in medium-sized follicles at late than at early growing 
phase of first dominant follicle, and is less in dominant E2-active than subordinate E2-
inactive follicles, indicating that FGF9 signaling could contribute to normal follicle 
development and steroidogenesis in dairy cattle. 
Key Words: Fibroblast growth factor-9 (FGF9), theca cell, granulosa cell, follicle 
growth, cattle. 
2. Introduction 
Fibroblast growth factors (FGFs) constitute a large family of polypeptide growth 
factors present in both vertebrates and invertebrates (Ornitz and Itoh, 2001). These growth 
factors and their receptors are distributed in various tissues and regulate development, 
metabolism and disease through intracrine, paracrine and endocrine mechanisms of action 
(Itoh and Ornitz, 2011). FGF family members have also been identified to play important 
roles in the reproduction of mammals including the human, caprine, ovine, bovine and murine 
species (for review see Chaves et al., 2012). To date, FGF1, FGF2, FGF7-9, FGF10, FGF17 
and FGF18 have been identified in the ovary of humans (Oron et al., 2012), rodents 
(Drummond et al., 2007), and/or domestic animals (Berisha et al., 2004; Machado et al., 
2009; Portela et al., 2010). Functions of FGF members in the ovary include regulation of 
granulosa cell (GC) steroidogenesis of cattle and pigs (Vernon and Spicer, 1994; Schreiber 
and Spicer, 2012; Evans et al., 2014), regulation of GC apoptosis and survival in rats (Tilly et 
al., 1992; Peluso et al., 2001) and cattle (Portela et al., 2010; Jiang and Price, 2012), control 
of bovine GC proliferation and differentiation (Berisha et al., 2004; Schreiber and Spicer, 
2012), oocyte maturation in rats and cattle (LaPolt et al., 1990; Cho et al., 2008), and luteal 
development in cattle (Gabler et al., 2004; Woad et al., 2012). 
Abundance of FGF9 mRNA was first observed to be down-regulated in GC of cystic 
follicles of cattle compared with noncystic follicles in a microarray study, indicating that 




Subsequently, abundance of FGF9 mRNA was found to be greater in GC than in theca cells 
(TC) and greater in both GC and TC in small follicles (i.e., 1-5 mm) in comparison to large 
(i.e., ≥ 8 mm) follicles (Schreiber et al., 2012). Hormones known to be involved in follicular 
development (e.g., insulin-like growth factor 1; IGF1) also regulate FGF9 mRNA in both GC 
(Schreiber and Spicer, 2012) and TC (Schreiber et al., 2012). Furthermore, FGF9 treatment 
stimulated bovine GC and TC proliferation while down-regulating hormone-stimulated 
steroidogenesis and steroidogenic enzyme gene expression, indicating a role for FGF9 as an 
anti-differentiation factor regulating folliculogenesis (Schreiber and Spicer, 2012; Schreiber 
et al., 2012). Increased free IGF1 may amplify FSH-induced estradiol (E2) production in the 
developing dominant follicle of cattle (Spicer, 2004). However, whether endogenous 
production of FGF9 by ovarian follicular cells changes during selection of dominant follicles 
in monotocous mammals such as cattle is still unknown. We hypothesized that FGF9 mRNA 
decreases as follicles grow and differentiate. Therefore, the objective of this study was to 
determine if abundance of FGF9 mRNA in GC and TC changes during growth of first-wave 
dominant follicles in dairy cattle exhibiting regular estrous cycles.  
3. Materials and Methods  
 Animals and Experimental Design 
Non-lactating Holstein cows (n = 18) were used for this experiment as previously 
described (Dentis et al., 2016). Briefly, estrous cycles were synchronized using two injections 
(im) of PGF2α (Lutalyse®, 25 mg) with an interval of 11 days. From the first injection of 
prostaglandin F2α to the occurrence of ovulation after the second injection, follicle 
development was monitored daily via ultrasonography using an Aloka 500V with a 7.5 MHz 
probe. Following ovulation, cows continued to be monitored with daily ultrasonography and 
were assigned to be ovariectomized either at d 3 to 4 (early growing phase of the first 
dominant follicle; n = 9 cows) or d 5 to 6 (late growing phase of the first dominant follicle; n 




to 4 post-ovulation and one from day 5 to 6 post-ovulation groups) to ovulate and were 
excluded from this experiment. After each ovariectomy, ovaries were put on ice, and 
transported to the laboratory where diameters of all follicles ≥ 5 mm (surface diameter) in 
diameter were recorded, the numbers of all follicles ≥ 1 mm in diameter on the ovarian 
surface determined, and ovarian tissue and fluid collected (Dentis et al., 2016). The animal 
experimentation described in this report was approved by the Oklahoma State University 
Institutional Animal Care and Use Committee (Protocol No. AG106). 
Cell and Follicular Fluid Collection 
For GC sample collection, follicles were categorized by surface diameter as small (1-
5 mm), medium (5.1-8 mm) or large (8.1-18 mm); TC samples were collected from only 
medium and large follicles. Follicular fluid (FFL) from medium and large follicles was 
aspirated individually and centrifuged to obtain GC; FFL from small follicles was pooled 
within each ovary and then centrifuged at 200 x g for 8 min to obtain GC as previously 
described (Stewart et al., 1996; Dentis et al., 2016). After centrifugation, FFL was aspirated 
and stored at -20 °C for measurement of E2 and progesterone (P4) via RIA. After collection 
of FFL, each medium and large follicle was bisected in situ, the inner wall was scraped, 
rinsed with Ham’s F-12 to remove any remaining GC, and these GC were combined with GC 
collected from FFL as previously described (Schreiber and Spicer, 2012; Dentis et al., 2016). 
GC collected from small follicles were kept separate for each ovary. GC were lysed in 0.5 mL 
of TRIzol® reagent solution (Life Technologies, Inc., Grand Island, NY) and stored frozen at 
-80 °C until RNA extraction (see description below). TC were dissected from the bisected 
follicles and placed in 0.75 mL of TRIzol® reagent solution and homogenized for 2-3 min on 
ice using the Omni TH tissue homogenizer (Omni International Inc., Marietta, GA) with 
Omni Tip™ disposable generator probes as previously described (Aad et al., 2012; Aad et al., 
2013). 




RNA was extracted from GC and TC as described elsewhere (Lagaly et al., 2008). 
Phase Lock GelTM (5 Prime, Inc., Gaithersburg, MD) tubes were used to aid in the recovery of 
aqueous phase containing RNA. RNA samples were solubilized in diethylpyrocarbonate-
treated water (Life Technologies, Inc.), quantified at 260 nm using a NanoDrop ND-1000 
spectrophotometer (NanoDrop Technologies Inc., Wilmington, DE), and stored at -80 °C.  
FGF9 primers and probe (supplied as 5’ FAM reporter dye and a 3’ TAMRA 
quencher dye; TaqMan TAMARA; Applied Biosystems Inc., Foster City, CA) for qPCR were 
designed using Primer Express software (Foster City, CA) as previously reported (Grado-
Ahuir et al., 2011; Schreiber and Spicer, 2012). The FGF9 mRNA (697 bp; Accession 
NM_001245926.1) forward primer was constructed between bp 387 and 408 with a Tm of 
58°C and a sequence of 5’-TCTACCTCGGCATGAATGAGAA-3’. The reverse FGF9 
mRNA primer was constructed between bp 476 and 497 with a Tm of 57°C and a sequence of 
5’- TGGAGGAGTACGTGTTGTACCA-3’. The FGF9 mRNA probe was constructed 
between bp 421 and 444 with a Tm of 66°C and a sequence of 5’-
TGGATCGGAAAAACTCACGCAAGA-3’. Relative mRNA abundance of target genes was 
quantified using fluorescent single-step qPCR using an ABI Prism® 7500 sequence detection 
system (Applied Biosystems). Target gene expression was normalized to constitutively 
expressed 18S ribosomal RNA (18S rRNA; supplied as a VIC probe; TaqMan Ribosomal 
RNA Control Reagent, Applied Biosystems Inc.), which has been reported as a valid 
housekeeping gene for bovine GC and TC (Voge et al., 2004), and relative quantity of target 
gene mRNAs was expressed as 2-ΔΔCt using the relative comparative threshold cycle (Ct) 
method as previously described (Livak and Schmittgen, 2001; Lagaly et al., 2008). 
Radioimmunoassays (RIA) and IGF1 ELISA 
Concentrations of P4 and E2 in FFL were determined by RIA as previously described 




steroid RIA. The intra-assay coefficient of variation for P4 and E2 RIA averaged 11.6 % and 
10.6 %, respectively. 
Free IGF1 concentrations in FFL were determined in a subset of samples (n = 32) via 
a free IGF1 ELISA kit (R&D Systems, Minneapolis, MN) according to the manufacturer’s 
protocol similar to previously described (Santiago et al., 2005; Spicer et al., 2005). If sample 
values were below the limit of detection of the assay, a 0.2 ng/mL value was assigned to that 
sample. All samples were quantified in one assay and the intra-assay coefficient of variation 
averaged 6.9 %. 
FGF9 Western Blotting 
Western blotting was utilized in an attempt to detect FGF9 protein in FFL. Protease 
inhibitor cocktail for use with mammalian cell and tissue extracts (Sigma-Aldrich, St Louis, 
MO) at 1:30 and sample buffer (tris-hydrochloride buffer, 10% SDS, glycerol, bromophenol 
blue, and β–mercaptoethanol) at 1:3 were added to FFL samples. Recombinant human FGF9 
(R&D systems Inc., Minneapolis, MN) was added to FFL (at a total amount of 2.5 ng) and 
PBS (at total amounts of 5 ng, 1 ng, and 0.1 ng) samples for evaluation of sensitivity of 
detection. Samples were boiled for 5 min, cooled down, centrifuged at 2000 x g for 1 min, 
and loaded into 4% stacking, 12% resolving SDS-PAGE mini gels. Precision Plus Protein™ 
Kaleidoscope™ Standards (Bio-Rad Laboratories, Inc., Hercules, CA) were added for 
monitoring electrophoretic separation and molecular weight sizing. Gels were ran at 120 V, 
for 80 min. Gels were transferred to nitrocellulose membranes via iBlot® Gel Transfer 
Device (Life Technologies, Inc., Carlsbad, California). After transfer, the nitrocellulose 
membranes were blocked in Tris-buffered saline (TBS) containing 5% (w/v) nonfat dry milk 
for 1 h at room temperature and then incubated with a FGF9 antibody (rabbit polyclonal 
antibody against human FGF9; Santa Cruz Biotechnology, Inc., Dallas, TX) at 1:250 
overnight at 4oC. Membranes were washed with a mixture of Tris-buffered saline and Tween 




conjugated goat anti-rabbit IgG, Pierce Biotechnology, Rockford, IL) diluted in TBS 
containing 5% (w/v) nonfat dry milk at 1:50,000 for 1 h at room temperature on a rocking 
platform shaker. Membranes were then washed again with TBST, dried, and incubated with 
enhanced chemiluminescent (ECL) substrate (SuperSignalTM West Femto maximum 
sensitivity substrate; Thermo Fisher Scientific, Inc., Waltham, MA) for 5 min at room 
temperature. Finally, membranes were developed via the FluorChemTM E system Imager 
(ProteinSimple; San Jose, CA) on movie mode for 180 min chemiluminescence detection. 
Statistical Analyses 
The analysis of data aimed to determine if FGF9 mRNA abundance differs in GC and 
TC at different periods of follicular development and to detect its relationship with 
steroidogenesis. Data were analyzed via factorial ANOVA with GLM procedures of SAS for 
Windows (version 9.2, SAS Institute Inc., Cary, NC) and are presented as the least squares 
means (± SEM) of measurements. Main factors were days post-ovulation (early, day 3-4, and 
late, day 5-6, growing phase of the first dominant follicle), and follicle status based on size 
and follicle estrogenic status [large E2 active (E2>P4 concentrations), and small, medium, or 
large E2 inactive (E2<P4 concentrations) in the case of GC; and large E2 active and medium 
or large E2 inactive in the case of TC], and their various interactions. Some cows had two E2-
active follicles on day 3-4 whereas some cows had no E2-active follicles on day 5-6.  Also, if 
FFL samples were lost during collection, then E2-status could not be determined and gene 
expression data was not included in the analysis.  For analysis of E2 and free IGF1 
concentrations in the subset of FFL samples, main factors were days post-ovulation (early, 
day 3-4, and late, day 5-6, growing phase of the first dominant follicle), follicle status (n = 3) 
based on size (small EI, large EA or large EI) and their various interaction. To correct for 
heterogeneity of variance, abundance of FGF9 mRNA was analyzed after transformation to 
natural log (x + 1). Mean differences were determined by Fisher’s protected least significant 
differences test (Ott, 1977) only if significant main effects in the ANOVA were detected. To 




generated using CORR procedure of SAS (SAS Institute). Significance was declared at P < 
0.05.   
4. Results 
GC FGF9 mRNA Abundance 
Averaged across follicle size groups, qPCR results indicated that FGF9 mRNA 
abundance in GC was 6.2-fold greater (P < 0.05) than in TC, and that GC FGF9 mRNA 
abundance was 2.9-fold greater (P < 0.05) at late (day 5-6 post-ovulation) than at early (day 
3-4 post-ovulation) growing phase of the first dominant follicle (145 ± 46 and 49 ± 7, 
respectively). Abundance of FGF9 mRNA was greater (P < 0.01) in large, medium, and small 
E2-inactive (E2/P4 ratio < 1) than in large E2-active (E2/P4 ratio > 1) follicles at both early 
(19-, 27- and 18-fold greater, respectively) and late (35-, 77- and 32-fold greater, 
respectively) growing phases of first dominant follicle (Figure 1A). Also, when E2-inactive 
follicles of same size were compared at different days post-ovulation, FGF9 mRNA 
abundance was 3.7-fold greater (P < 0.01) in medium-sized follicles at late than at early 
growing phase of the first dominant follicle while no significant differences were detected 
between large or small E2-inactive follicles (Figure 1A). Abundance of FGF9 mRNA in GC 
was 2.2–fold greater (P < 0.01) in E2-inactive medium- and small-sized follicles than in E2-
inactive large-sized follicles at late growing phase (day 5-6) of the first dominant follicle, 
with no significant differences observed between other sizes at this phase or between any of 
the E2-inactive follicle sizes at day 3-4 post-ovulation (Figure 1A). Averaged across days, 
FGF9 mRNA abundance in GC was several-fold greater (P < 0.01) in large (70.6 ± 14.1), 
medium (179.6 ± 38.6), and small (90.5 ± 21.1) E2-inactive than in large E2-active follicles 
(5.1 ± 1.0). 




No significant interaction existed between days post-ovulation and follicle status for 
TC FGF9 mRNA abundance. In contrast to what was observed in GC, averaged across 
follicle size groups there was a tendency (P = 0.05) for TC FGF9 mRNA abundance to be 
greater in early (2.7 ± 3.1) than in late (1.6 ± 0.7) growing phase of the first dominant follicle. 
Abundance of FGF9 mRNA in TC was 2.2-fold greater (P < 0.05) in large subordinate E2-
inactive follicles than in large dominant E2-active follicles on day 3-4 post-ovulation (Figure 
1B). No other significant differences were detected between subordinate E2-inactive and 
large dominant E2-active follicles on day 5-6 post-ovulation, or between large E2-inactive 
follicles and medium E2-inactive follicles. Abundance of FGF9 mRNA in TC was greater in 
large subordinate E2-inactive follicles at day 3-4 than at day 5-6 post-ovulation, whereas no 
significant changes were observed in the other two groups of follicles (Figure 1B). 
Follicle Size, E2, P4 and Free IGF1 Concentrations in Follicular Fluid 
Follicle size and steroid concentrations in FFL have been reported for this study 
(Dentis et al., 2016). Briefly, diameter of large dominant E2-active, large subordinate E2-
inactive, and medium E2-inactive follicles averaged 12.9 ± 0.5, 9.48 ± 0.36, and 6.37 ± 0.23 
mm, respectively. Concentrations of E2 in FFL of large dominant E2-active, large 
subordinate E2-inactive, medium E2-inactive, and small E2-inactive follicles averaged 186.5 
± 29.5, 8.45 ± 3.7, 2.3 ± 0.8, and 2.0 ± 0.2 ng/ml, respectively.  Concentrations of P4 in FFL 
did not differ (P > 0.10) among follicle groups and ranged between 61 ± 7 and 236 ± 42 
ng/ml. 
In a subset of these samples (n=32) representative of a range of steroid levels, 
concentrations of E2, P4 and free IGF1 in large dominant E2-active, large subordinate E2-
inactive, and small E2-inactive follicles are shown in Figure 2.  Large dominant E2-active 
follicles had greater (P < 0.05) free IGF1 (Figure 2A) and E2 (Figure 2B) but tended to have 




Concentrations of free IGF1, E2 and P4 in large E2-inactive and small E2-inactive follicles 
did not differ (P > 0.10). 
Correlations between FFL Concentrations of Hormones and FGF9 mRNA Relative 
Abundance 
Negative correlations existed between GC FGF9 mRNA abundance and FFL E2 (r = 
- 0.68, P < 0.001; Figure 3) and E2/P4 ratio (r = -0.58, P < 0.001; n = 140). In contrast, there 
was a weak positive correlation (r = 0.18, P < 0.05) between GC FGF9 mRNA abundance 
and FFL P4. No significant correlation was observed between TC FGF9 mRNA abundance 
and FFL P4 (r = 0.06, P > .50), but there was a weak negative correlation between TC FGF9 
mRNA abundance and FFL E2 (r = -.26, P < 0.05) and E2/P4 ratio (r = - 0.22, P = 0.05; n = 
88).  Free IGF1 concentrations in FFL and GC FGF9 mRNA abundance were negatively 
correlated (r = -0.63, P < 0.001; n = 32), whereas free IGF1 concentrations and E2 
concentrations in FFL were positively correlated (r = 0.85, P < 0.001). There was no 
significant correlation between FFL concentrations of P4 and free IGF1 (r = -0.19, P > 0.10).  
The E2/P4 ratio was positively correlated with free IGF1 in FFL (r = 0.63, P < 0.001). 
FGF9 Protein in FFL 
Recombinant human FGF9 protein was detected via Western blotting at total amounts 
of 5 ng and 1 ng in 15 µL of PBS and 5 µL of sample buffer, and at a total amount of 2.5 ng 
in 5 µL FFL, 10 µL of PBS, and 5 µL of sample buffer (i.e., an equivalent sensitivity of 125 
ng/mL of FFL). The sensitivity of the antibody, however, was not adequate to detect 
recombinant human FGF9 protein at a total amount of 0.1 ng in 15 µL of PBS and 5 µL of 
sample buffer or to detect endogenous FGF9 protein in either 10 µL of FFL, 5 µL of PBS, and 
5 µL of sample buffer, or 5 µL of FFL, 10 µL of PBS, and 5 µL of sample buffer (Figure 4). 
 




FGF9 has been characterized as an anti-differentiation factor in folliculogenesis of 
cattle, stimulating both GC and TC proliferation while inhibiting steroidogenesis (Schreiber 
and Spicer, 2012; Schreiber et al., 2012). In the present study, we report for the first time that 
FGF9 mRNA abundance in GC and TC changes according to E2 activity and size of follicles, 
and also during follicle development in cattle. 
In the present study, follicles were collected at specific days of a synchronized cycle 
during the first follicular wave and thus represent a well-defined physiologic model. 
Consistent with what is expected from a factor that stimulates cells to proliferate while 
inhibiting their differentiation by decreasing E2 production (as described in Schreiber and 
Spicer, 2012), the abundance of FGF9 mRNA in GC was less in large dominant E2-active 
follicles at early and late growing phases of the first follicular wave than in subordinate E2-
inactive follicles of various sizes, indicating that FGF9 production likely decreases as the 
follicle becomes dominant and increased steroidogenesis is required for its further 
differentiation. In support of this latter suggestion, FFL E2 concentrations and E2:P4 ratio 
were negatively correlated with GC FGF9 mRNA abundance in the present study.  
Alternatively, increased E2 may directly inhibit FGF9 mRNA expression in GC, but this is 
unlikely because in vivo, diethylstilbesterol (DES) treatment had no significant effect on 
ovarian FGF9 mRNA expression in rats (Drummond et al., 2007), and in vitro, E2 had no 
significant effect on bovine GC FGF9 mRNA abundance (Schreiber and Spicer, 2012). The 
absence of any change in FFL P4 concentrations during significant changes in both GC and 
TC FGF9 mRNA indicates that P4 likely does not regulate FGF9 mRNA. Also in the present 
study, GC FGF9 mRNA increased in medium E2-inactive follicles as the follicular wave 
advanced from early to late in the growing phase of the first dominant follicle resulting in a 
greater abundance of FGF9 mRNA in medium than in large-sized follicles at day 5-6 post-
ovulation. Perhaps FGF9 is important to assure that only one follicle will differentiate and 
dominate at the end of the first follicular wave in a monovulatory species such as the bovine. 




subordinate versus dominant follicles (Portela et al., 2010), and a greater abundance of FGF2 
mRNA (Berisha et al., 2004) and FGF10 mRNA (Buratini et al., 2007) in TC of estrogenic 
versus non-estrogenic antral follicles.  In contrast, FGF1 and FGF7 mRNA abundance in GC 
and TC do not change during follicular development in cattle (Berisha et al., 2004) or pigs 
(Schams et al., 2009). Collectively, the previous and present studies indicate different 
developmental control of the various FGFs in GC and TC of follicles during folliculogenesis.  
As mentioned, E2 does not directly affect FGF9 mRNA abundance in GC (Schreiber 
and Spicer, 2012), suggesting that one or more hormone(s) or intraovarian factor(s) other than 
E2 is(are) the cause for lower abundance of FGF9 mRNA in GC of large dominant EA 
follicles. One of these other intraovarian factors may be IGF1 because IGF1 decreases 
abundance of FGF9 mRNA in GC from both small and large follicles (Schreiber and Spicer, 
2012), and concentrations of free IGF1 in FFL increase in early dominant follicles (Fortune et 
al., 2001; Spicer, 2004) as well as in preovulatory dominant follicles (Santiago et al., 2005) in 
cattle. Also, the fact that IGF-1 suppresses Indian hedgehog production in TC (Spicer et al., 
2009) and that sonic hedgehog (SHH) stimulates FGF9 production in the ovary (Schreiber 
and Spicer, 2012) and other tissues (Sun et al., 2000) indicate that hedgehog proteins may be 
important in FGF9 signaling in the ovary (Figure 5). In addition, we observed that wingless-
type mouse mammary tumor virus integration site (WNT)-3A protein inhibited GC FGF9 
mRNA (Schreiber and Spicer, 2012). WNTs are secreted ligands that bind to frizzled (FZD) 
receptor proteins and subsequently transmit their intracellular signals (Grado-Ahuir et al., 
2011; Castanon et al., 2012). Recent findings indicate that GC of dominant follicles have 
greater FZD6 mRNA than subordinate follicles (Gupta et al., 2014) and that FSH increases 
mRNA abundance of one of FZD6 ligands, WNT2, in bovine granulosa cells (Castanon et al., 
2012). Thus, we hypothesize that during dominant follicle development, increases in free 
IGF1 (Fortune et al., 2001; Spicer, 2004) and WNT signaling (Gupta et al., 2014) cause a 





Similar to what was found for GC, there was a negative correlation between TC 
FGF9 mRNA and E2/P4 ratio in FFL. Also, TC of large E2-inactive follicles had greater 
abundance of FGF9 mRNA than large E2-active follicles, but only at day 3-4 post-ovulation. 
Hormones that regulate TC FGF9 mRNA abundance have not been studied in any detail.  
Interestingly, factors (i.e., TNFα and WNT3A) that inhibit FGF9 mRNA in GC (Schreiber 
and Spicer, 2012) and inhibit androstenedione production by TC (Spicer, 1998) were found to 
stimulate FGF9 mRNA in TC (Schreiber et al., 2012). We further hypothesize that IGF1 and 
WNTs may act in a negative feedback loop within TC promoting FGF9 production to avoid 
premature differentiation of dominant follicles. Consistent with an opposing regulation of 
FGF9 mRNA in TC versus GC is the general trend that FGF9 mRNA was greater in TC and 
lower in GC at day 3-4 in comparison to day 5-6 post-ovulation in the present study. Further 
work will be required to elucidate the hormonal and developmental control of TC FGF9 
mRNA. 
In the present study, regardless of follicle size, FGF9 mRNA abundance was greater 
in GC than in TC; this is in agreement with a previous study (Schreiber et al., 2012) and 
indicates that GC is the main cell type responsible for ovarian follicle production of FGF9. 
Also, abundance of FGF9 mRNA in GC varied more dramatically with follicle status than in 
TC, further suggesting a greater importance for GC in FGF9 production during 
folliculogenesis in cattle. Unfortunately, the two commercial ELISA kits available to measure 
FGF9 protein (i.e., bovine FGF9 ELISA, NovateinBio, Inc., Cambridge, MA; human FGF9 
ELISA, R&D Systems, Minneapolis, MN) did not have adequate sensitivity to detect FGF9 
protein in bovine FFL in the present study (Spicer and Schütz, unpublished results). 
Furthermore, attempts to use Western blotting to detect FGF9 in FFL were unsuccessful, most 
likely because of the small quantities of protein produced. Sensitivity of detection was 50 
ng/mL in PBS and 125 ng/mL in FFL. Based on in vitro studies with half maximal inhibitory 
concentrations of FGF9 ranging between 2 and 12 ng/mL (Schreiber and Spicer, 2012; 




estimation of sensitivity of Western blotting system would need to be increased by 5- to 50-
fold. Additional developmental work will be required to ascertain changes in FFL FGF9 
protein levels during follicular growth and atresia. 
In summary, FGF9 mRNA abundance in both GC and TC changed during 
development of dominant and subordinate follicles in cattle. Abundance of FGF9 mRNA was 
greater in GC than in TC and the more dramatic change in FGF9 mRNA in GC vs. TC 
indicate a greater importance for GC in ovarian FGF9 production during folliculogenesis in 
cattle. Dramatically less FGF9 mRNA abundance in dominant E2-active follicles than in E2-
inactive subordinate follicles is consistent with what is expected from an anti-differentiation 
factor.  We postulate, as a framework for future studies and based on the experimental data 
presented in this paper, that FGF9 may play a role in follicular growth and atresia in cattle. 
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Fig. 1. Abundance of FGF9 mRNA in granulosa and theca cells during follicular 
growth. Panel A: Effects of follicular size (Lg = Large; Md = Medium; Sm = Small) and E2 
status (EA = estrogen active; EI = estrogen inactive) on FGF9 mRNA in bovine granulosa 
cells on different days post-ovulation. abcMeans without a common letter differ (P < 0.05); n = 
10, 16, 36 and 16 for Lg-EA, Lg-EI, Md-EI and Sm-EI, respectively, for day 3-4; n = 5, 17, 
27 and 14 for Lg-EA, Lg-EI, Md-EI and Sm-EI, respectively, for day 5-6.  Panel B: Effect of 
follicular size (Lg = Large; Md = Medium) and E2 status (EA = estrogen active; EI = 
estrogen inactive) on abundance of FGF9 mRNA in bovine theca cells on different days post-
ovulation. abMeans without a common letter differ (P < 0.05);  n = 9, 13 and 28 for Lg-EA, 
Lg-EI and Md-EI, respectively, for day 3-4; n = 4, 11 and 23 for Lg-EA, Lg-EI and Md-EI, 
respectively, for day 5-6.  Values are normalized to constitutively expressed 18S ribosomal 
























Fig. 2.  Effects of follicular size (Lg = Large; Sm = Small) and E2 status (EA = 
estrogen active; EI = estrogen inactive) on concentrations of free IGF1 (Panel A), E2 and P4 
(Panel B) in follicular fluid. abMeans (n = 6-18 follicles per group) without a common letter 















Fig. 3. Correlation between FGF9 mRNA abundance in granulosa cells and 
concentrations of E2 in follicular fluid (FFL). The relationship between FGF9 mRNA 
abundance and concentrations of E2 in FFL collected between days 3 and 6 post-ovulation is 










Fig. 4. Results from Western blotting to detect FGF9 protein in FFL. Lanes were 
loaded as following (from left to right): negative control (0 ng of recombinant human FGF9 
in PBS); 5 ng of recombinant human FGF9 in 15 µL of PBS and 5 µL of sample buffer; 1 ng 
of recombinant human FGF9 in 15 µL of PBS and 5 µL of sample buffer; 0.1 ng of 
recombinant human FGF9 in in 15 µL of PBS and 5 µL of sample buffer; 2.5 ng of 
recombinant human FGF9 in 5 µL FFL, 10 µL of PBS, and 5 µL of sample buffer; 10 µL of 
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Fig. 5. Schematic model summarizing the hormonal regulation of FGF9 production 
by granulosa and theca cells. Dashed line with T at end indicates inhibitory effects; hormones 
by arrows with a “+” indicates stimulatory effects; hormones by arrows with a “˗” indicates 
inhibitory effects. IGF1, FSH and LH are stimulatory to estradiol (E2) and androstenedione 
(A4) production via interaction with 17-hydroxylase (CYP17A1) and aromatase (CYP19A1). 
Increased WNT2 and free IGF1 decreases FGF9 mRNA and this decreased FGF9 production 
causes a reduction in the FGF9 inhibition of E2 production by granulosa cells (GC) and A4 
production by theca cells (TC), causing an overall increase in E2 production by the dominant 
follicle. SHH, Sonic hedgehog; T4, thyroxine; TNFa, tumor necrosis factor alpha; WNT2, 
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CHANGES IN FIBROBLAST GROWTH FACTOR RECEPTORS-1c, -2c, -3c, 




Fibroblast growth factors (FGFs) regulate folliculogenesis of several mammalian 
species, including cattle, through autocrine, paracrine, and endocrine mechanisms. The 
diversity of roles played by FGFs is influenced by the nature of the ligands and the diversity 
of high affinity fibroblast growth factors receptors (FGFRs). There are four distinct genes 
encoding for FGFRs (FGFR1-FGFR4) in vertebrates and the occurrence of mRNA splicing in 
the immunoglobulin-like domain III generates diversity of sequence and results in various 
isoforms of FGFR1, FGFR2, and FGFR3 genes (but not of FGFR4). Because FGFRs have 
different ligand-specificities, the localization of FGFRs in the different compartments of 
bovine antral follicles is of fundamental importance for the FGFs to exert their effects in the 
ovary. Hence, the objective of this study was to determine if FGFR1c, FGFR2c, FGFR3c, and 
FGFR4 change according to follicular size, steroidogenic status, and days post-ovulation 
during growth of first-wave dominant follicles in cattle exhibiting a regular estrous cycle. 
Estrous cycles of non-lactating dairy cattle were synchronized, and ovaries were collected on 
either day 3-4 (n = 8) or day 5-6 (n = 8) post-ovulation for GC and TC mRNA extraction 
from small (1-5 mm), medium (5.1-8 mm) or large (8.1-18 mm) follicles for real time-PCR 
analysis. In GC, FGFR1c and FGFR2c mRNA relative abundance was greater (P < 0.01) in 
estrogen (E2)-inactive (i.e., concentrations of E2 < progesterone, P4) follicles of all sizes than 
in GC from large E2-active follicles (i.e., concentrations of E2 < P4), FGFR3c mRNA 
relative abundance was greater (P < 0.05) in large and medium E2-inactive than in large  E2-




follicles. In TC, medium E2-inactive follicles had greater (P < 0.05) FGFR1c and FGFR4 
mRNA abundance than large E2-active and E2–inactive follicles at the late growing phase of 
the first dominant follicle whereas FGFR1c, FGFR2c, FGFR3c, and FGFR4 mRNA 
abundance was greater (P < 0.05) in medium E2-inactive follicles at late (day 5-6 post-
ovulation) than at early (day 3-4 post-ovulation) growing phase of first dominant follicle. 
Taken together, the findings that FGFR1c, FGFR2c, and FGFR3c mRNA abundance was less 
in GC of E2-active follicles and was greater in TC of medium inactive follicles at late than at 
early growing phase of first dominant follicle for all FGFRs isoforms tested support an anti-
differentiation role for FGFs and their FGFRs as well as support the idea that changes in 
FGFs and their receptors regulate selection of dominant follicles in cattle. 
Key Words: Fibroblast growth factor receptors (FGFRs), FGFR1c, FGFR2c, 
FGFR3c, FGFR4, theca cell, granulosa cell, cattle. 
2. Introduction 
Ovarian folliculogenesis is a tightly regulated process where the somatic cells of the 
follicle, granulosa (GC) and theca (TC) cells, communicate in a coordinated way with the 
oocyte for both follicular and oocyte growth and maturation (Eppig, 1991; Elvin and Matzuk, 
1998; Fortune et al., 2004). Among other growth factors that control folliculogenesis, the 
fibroblast growth factors (FGFs) have been emerging as important regulators of ovarian 
function, playing autocrine, paracrine, and endocrine roles in the regulation of development 
of ovarian follicles (for reviews, see Chaves et al., 2012; Price, 2016). These polypeptides 
belong to a family of 22 members in mammals (Ornitz and Itoh, 2001; Itoh and Ornitz, 2011), 
and, to date, ten members have been detected in the ovary: FGF1, 2, 7-10, 16-18, 22. In antral 
follicles of cattle, FGF1, FGF2, FGF7, FGF18, and FGF22 are mainly produced by TC 
(Parrott and Skinner, 1998; Berisha et al., 2000; Berisha et al., 2004; Buratini et al., 2007; 
Portela et al., 2010; Castilho et al., 2015); FGF8 is produced by GC, TC, and oocytes 




al., 2012); FGF10 is produced by TC and oocytes (Buratini et al., 2007); FGF16 is produced 
by the oocyte (Ferreira et al., 2016); and FGF17 is detected mainly in oocytes, but also in GC 
(Machado et al., 2009). 
In cattle, FGFs play diverse roles in ovarian function. To date, at least four members 
of this polypeptide family stimulate proliferation of somatic cells of ovarian follicles: FGF1, 
FGF2, FGF7, and FGF9 stimulate GC and/or TC proliferation (Gospodarowicz et al., 1977a; 
Gospodarowicz et al., 1977b; Gospodarowicz et al., 1985; Parrott et al., 1994; Spicer and 
Stewart, 1996; Schreiber and Spicer, 2012; Schreiber et al., 2012). In addition, FGFs regulate 
steroidogenesis: FGF2, FGF7, and FGF18 inhibit FSH-stimulated estradiol (E2) and LH-
stimulated progesterone (P4) production by GC (Vernon and Spicer, 1994; Spicer and 
Stewart, 1996; Wandji et al., 1996; Parrott and Skinner, 1998; Machado et al., 2009; Portela 
et al., 2010); FGF9 attenuates insulin-like growth factor 1-stimulated E2 and P4 production 
by GC (Schreiber and Spicer, 2012) and suppresses insulin-like growth factor 1-stimulated P4 
production by TC (Schreiber et al., 2012). 
In order to exert their actions in the ovary, FGFs need to bind to high affinity 
receptors (FGFRs). The FGFR is a single chain transmembrane tyrosine kinase with two or 
three immunoglobulin-like domains and a heparin-binding domain in the extracellular ligand-
binding portion (Plotnikov et al., 2000; Ornitz and Itoh, 2001; Itoh and Ornitz, 2004; Li et al., 
2016). There are four distinct genes encoding for FGFRs (FGFR1-FGFR4) in vertebrates and 
mRNA alternative splicing occurs in the immunoglobulin-like domain III of the FGFR1, 
FGFR2, and FGFR3 genes (but not of FGFR4), generating diversity of sequence and 
resulting in various isoforms (Itoh and Ornitz, 2004; Ornitz and Itoh, 2015; Li et al., 2016). 
The ligands of the FGF family have different affinities for these receptors (Itoh and Ornitz, 
2004), which are determined by the immunoglobulin-like domains (Dell and Williams, 1992). 
According to ligand binding specificity, the preferred receptors for FGFs produced in the 
ovary are: FGFR1c for FGF1 and FGF2; FGFR2b for FGF7, FGF10, and FGF22; FGFR3c 




addition, FGFR1b is the second preferred for FGF7, FGF10, and FGF22; FGFR2c is the 
second preferred for FGF9 and FGF16; and FGFR4 is the second preferred for FGF8, FGF17, 
and FGF18 (Ornitz and Itoh, 2015). 
Since FGFRs have different ligand-specificities, the localization of FGFRs in the 
different compartments of bovine antral follicles is of fundamental importance for the FGFs 
effects: FGFR1b has been detected in GC, TC, and oocytes (Zhang and Ealy, 2012; Castilho 
et al., 2015); FGFR1c and FGFR2b have been detected in GC and oocytes (Berisha et al., 
2004; Buratini et al., 2007; Machado et al., 2009; Zhang and Ealy, 2012); FGFR2c and 
FGFR3c have been detected in both GC and TC (Berisha et al., 2004; Buratini et al., 2005); 
FGFR4 has been detected exclusively in TC (Buratini et al., 2005). In addition, some FGFRs 
change according to follicular fate in cattle: FGFR1b and FGFR2b GC mRNA abundance is 
greater in future subordinate follicles than in future dominant follicles (Berisha et al., 2004; 
Castilho et al., 2015); FGFR3c mRNA abundance is greater in GC (but not in TC) of small 
healthy follicles and in response to FSH (Buratini et al. 2005); FGFR4 mRNA abundance is 
greater in small than in large follicles (Buratini et al., 2005). Nevertheless, information of 
how endogenous production of FGFRs by ovarian follicular cells change during selection of 
dominant follicles in cattle needs further clarification. Hence, the objective of this study was 
to determine if mRNA abundance of FGFR1c, FGFR2c, FGFR3c, and FGFR4 in GC and TC 
changes during growth of first-wave dominant follicles in cattle exhibiting regular estrous 
cycle. 
3. Material and Methods 
Animals and Experimental Design 
Non-lactating Holstein cows (n = 16), culled for non-reproductive reasons from 
Oklahoma State University herd, were used for this experiment as previously described 
(Dentis et al., 2016). Briefly, estrous cycles were synchronized using two injections (i.m.) of 




development was monitored daily via ultrasonography using an Aloka 500V with a 7.5 MHz 
probe. Following ovulation, cows were assigned to be ovariectomized either at day 3-4 (early 
growing phase of the first dominant follicle; n = 8 cows) or day 5-6 post-ovulation (late 
growing phase of the first dominant follicle; n = 8 cows). After each ovariectomy, ovaries 
were put on ice, and transported to the laboratory where diameters of all follicles ≥ 5 mm 
(surface diameter) in diameter were recorded, and ovarian tissue and fluid collected (Dentis et 
al., 2016). The animal experimentation described in this report was approved by the 
Oklahoma State University Institutional Animal Care and Use Committee (Protocol No. 
AG106). 
Cell and Follicular Fluid Collection 
For GC sample collection, follicles were categorized by surface diameter as small (1-
5 mm), medium (5.1-8 mm) or large (8.1-18 mm); TC samples were collected from only 
medium and large follicles. Follicular fluid (FFL) from medium and large follicles was 
aspirated individually and centrifuged to obtain GC, and FFL from small follicles was pooled 
within each ovary and then centrifuged to obtain GC as previously described (Stewart et al., 
1996; Dentis et al., 2016). After centrifugation, FFL was aspirated and stored at -20 °C for 
measurement of E2 and P4 via RIA. After collection of FFL, each medium and large follicle 
was bisected in situ, the inner wall was scraped, rinsed with Ham’s F-12 to remove any 
remaining GC, and these GC were combined with GC collected from FFL as previously 
described (Schreiber and Spicer, 2012; Dentis et al., 2016). GC collected from small follicles 
were kept separate for each ovary. GC were lysed in 0.5 mL of TRIzol® reagent solution 
(Life Technologies, Inc., Grand Island, NY) and stored frozen at -80 °C until RNA extraction 
(see description below).  TC were dissected from the bisected follicles and placed in 0.75 mL 
of TRIzol Reagent and homogenized for 2-3 min on ice using the Omni TH tissue 
homogenizer (Omni International Inc., Marietta, GA) with Omni Tip™ disposable generator 
probes as previously described (Aad et al., 2012). 




Ovarian GC and TC mRNA was isolated as described elsewhere (Voge et al., 2004). 
RNA samples were solubilized in diethylpyrocarbonate-treated water (Life Technologies), 
quantitated at 260 nm using a NanoDrop ND-1000 spectrophotometer (NanoDrop 
Technologies Inc., Wilmington, DE), and stored at -80 °C.  
Primers and probes for FGFR1c, FGFR2c, FGFR3c, and FGFR4 (supplied as 5’ 
FAM reporter dye and a 3’ TAMRA quencher dye; TaqMan TAMARA; Applied Biosystems 
Inc., Foster City, CA) for quantitative qPCR (Table 1) were designed using Primer Express 
software (Foster City, CA) as previously reported (Grado-Ahuir et al., 2011). A “highly 
similar sequences” BLAST query search (http://blast.ncbi.nlm.nih.gov/Blast.cgi) was 
conducted for each primer and probe to ensure specificity of the designed primers and probes. 
Relative mRNA abundance of target genes was quantified using fluorescent quantitative 
single-step RT-PCR using a CFX96TM Real-Time PCR Detection System (Bio-Rad 
Laboratories, Inc., Hercules, CA). Target gene expression was normalized to constitutively 
expressed 18S ribosomal RNA (18S rRNA; supplied as a VIC probe; TaqMan Ribosomal 
RNA Control Reagent, Applied Biosystems Inc.) and relative quantity of target gene mRNAs 
was expressed as 2-ΔΔCt using the relative comparative threshold cycle (Ct) method as 
previously described (Livak and Schmittgen, 2001; Voge et al., 2004; Lagaly et al., 2008). 
Radioimmunoassays (RIA) 
Concentrations of P4 and E2 in FFL were determined by RIA as previously described 
(Stewart et al., 1996; Dentis et al., 2016). All samples were run in one assay for each of the 
steroid RIA. The intra-assay coefficient of variation for P4 and E2 RIA was 11.6 % and 10.6 
%, respectively. 
Statistical Analyses 
Through analysis of these data, we sought to determine if FGFR1c, FGFR2c, 
FGFR3c, and FGFR4 mRNA abundance varies in GC and TC at different periods of 




analyzed via factorial ANOVA with GLM procedures of SAS for Windows (version 9.2, SAS 
Institute Inc., Cary, NC) and are presented as the least squares means (± SEM) of 
measurements. Main factors were days post-ovulation (early, day 3-4, and late, day 5-6, 
growing phase of the first dominant follicle), and follicle status based on size (small, medium, 
or large in the case of GC, and medium or large in the case of TC) and estrogenic status (E2 
active: E2>P4 concentrations in FFL or E2 inactive: E2<P4 concentrations in FFL), and their 
interaction. Some cows had two E2-active follicles on day 3-4 whereas some cows had no E2-
active follicles on day 5-6. Also, if FFL samples were lost during collection, then E2-status 
could not be determined and gene expression data was not included in the analysis. To correct 
for heterogeneity of variance, target gene abundance was analyzed after transformation to 
natural log (x + 1). Mean differences were determined by Fisher’s protected least significant 
differences test (Ott, 1977) only if significant main effects in the ANOVA were detected. To 
evaluate the relationships among variables measured, Pearson correlation coefficients were 
generated using CORR procedure of SAS (SAS Institute). Because of the wide range and 
heterogeneous variances of the variables measured, log-transformed variables were correlated 
among each other. Significance was declared at P < 0.05. 
4. Results 
Follicle size, E2, and P4 Concentrations in follicular fluid 
Follicle size and steroid concentrations in FFL have been reported for this study 
(Dentis et al., 2016). Briefly, diameter of large dominant E2-active, large subordinate E2-
inactive, and medium E2-inactive follicles averaged 12.9 ± 0.5, 9.48 ± 0.36, and 6.37 ± 0.23 
mm, respectively. Concentrations of E2 in FFL of large dominant E2-active, large 
subordinate E2-inactive, medium E2-inactive, and small E2-inactive follicles averaged 186.5 
± 29.5, 8.45 ± 3.7, 2.3 ± 0.8, and 2.0 ± 0.2 ng/ml, respectively.  Concentrations of P4 in FFL 





GC FGFR1c mRNA Relative Abundance 
Abundance of FGFR1c mRNA, the main receptor for FGF1 and FGF2, was 
significantly affected by follicle group, but not by days post-ovulation or their interaction. 
Specifically, FGFR1c mRNA abundance was greater (P < 0.01) in large, medium, and small 
E2-inactive (E2/P4 ratio < 1) than in large E2-active (E2/P4 ratio > 1) follicles (4.3-, 6.1-, and 
4.2-fold, respectively) and was 1.4–fold greater (P < 0.05) in medium E2-inactive than in 
large and small E2-inactive follicles (Fig. 1A). No other significant differences were detected 
among follicles of different sizes and steroidogenic status. 
GC FGFR2c mRNA Relative Abundance 
Abundance of FGFR2c mRNA, the second main receptor for FGF9 and FGF16, was 
significantly affected by follicle group, but not by days post-ovulation or their interaction 
(Fig. 1B). Specifically, FGFR2c mRNA abundance was greater (P < 0.01) in large, medium, 
and small E2-inactive than in large E2-active follicles (7.5-, 10.4-, and 4.9-fold, respectively). 
No other significant differences were detected among follicles of different sizes and 
steroidogenic status. 
GC FGFR3c mRNA Relative Abundance 
Abundance of FGFR3c mRNA, the main receptor for FGF8, FGF9, FGF16, FGF17, 
and FGF18, was significantly affected by follicle group, but not by days post-ovulation or 
their interaction (Fig. 1C). Specifically, FGFR3c mRNA abundance was greater (P < 0.05) in 
large and medium E2-inactive than in large E2-active follicles (3.3- and 3.7-fold, 
respectively) and tended to be greater (P = 0.06) in small E2-inactive than in large E2-active 
follicles (Fig. 1C). No other significant differences were detected among follicles of different 
sizes and steroidogenic status. 




Abundance of FGFR4 mRNA was not different (P > 0.10) among follicles of 
different sizes and steroidogenic status or days post-ovulation (Fig. 1D). 
TC FGFR1c mRNA Relative Abundance 
Abundance of FGFR1c mRNA in TC was affected (P < 0.05) by follicle group, days 
post-ovulation, and their interaction. Specifically, FGFR1c mRNA abundance was (2.7- and 
1.7-fold, respectively) greater (P < 0.05) in medium E2-inactive than in large E2-active and 
small E2–inactive follicles at late growing phase of first dominant follicle (Fig. 2A). 
Moreover, FGFR1c mRNA abundance was 2–fold greater in medium E2-inactive at late than 
at early growing phase of first dominant follicle. No significant differences in FGFR1c 
mRNA abundance were detected between large E2-active, large E2-inactive and medium E2-
inactive follicles at early growing phase of first dominant follicle. 
TC FGFR2c mRNA Relative Abundance 
Abundance of FGFR2c mRNA tended (P < 0.07) to be affected by follicle group x 
days post-ovulation such that FGFR2c mRNA abundance was 1.9–fold greater (P < 0.05) in 
medium E2-inactive follicles at late than at early growing phase of first dominant follicle 
(Fig. 2B). No other significant differences were detected among follicles of different sizes 
and estrogen activity at early or late growing phases of first dominant follicle. 
TC FGFR3c mRNA Relative Abundance 
Abundance of FGFR3c mRNA tended (P < 0.10) to be affected by the follicle group 
by days post-ovulation interaction such that FGFR3c mRNA abundance was 2.7–fold greater 
(P < 0.05) in medium E2-inactive than in large E2-inactive follicles at late growing phase of 
first dominant follicle (Fig. 2C). In addition, FGFR3c mRNA abundance was 1.8–fold greater 
(P < 0.01) in medium E2-inactive follicles at late days post-ovulation than at early days post-
ovulation. No other significant differences were detected between follicles of different sizes 




TC FGFR4 mRNA Relative Abundance 
Abundance of FGFR4 tended (P < 0.09) to be affected by the follicle group by days 
post-ovulation interaction such that FGFR4 mRNA abundance was 1.4–fold greater (P < 
0.05) in medium E2-inactive at late days post-ovulation than at early days post-ovulation 
(Fig. 2D). In addition, FGFR4 mRNA abundance was (5.2- and 1.7-fold, respectively) greater 
(P < 0.05) in medium E2-inactive than in large E2-active and E2–inactive follicles at late 
growing phase of first dominant follicle. No other significant differences were detected 
between follicles of different sizes at early or late growing phases of first dominant follicle. 
Correlations among Follicular Size, FFL Levels of Steroids, and FGFRs mRNA Relative 
Abundance 
In GC, negative correlations existed between follicular size and FGFR1c (r = -0.30, P 
< 0.01, n = 141) and FGFR2c mRNA abundance (r = - 0.23, P < 0.01, n = 142). In TC, a 
negative correlation existed between follicular size and FGFR4 (r = -0.23, P < 0.05, n = 82). 
No significant correlations were observed between follicular size and FGFR3c or FGFR4 
mRNA abundance in GC or between follicular size and FGFR1c, FGFR2c, or FGFR3c 
mRNA abundance in TC. 
In GC, correlations between FFL concentrations of E2 and FGFRs mRNA abundance 
were negative for all FGFR isoforms. Specifically, a negative correlation existed between 
FFL E2 concentrations and FGFR1c (r = -0.20, P < 0.05, n = 136) and FGFR2c (r = -0.17, P 
< 0.01, n = 137) mRNA abundance. Also, log-transformed values of FGFR3c (r = -0.24, P < 
0.05, n = 135) and FGFR4 (r = -0.22, P < 0.05, n = 138) mRNA abundance were negatively 
correlated to levels of E2 and log-transformed values of levels of E2 in FFL, respectively. In 
TC, a negative correlation existed between FFL E2 concentrations and FGFR1c (r = -0.25, P 
< 0.05, n = 79) and between log-transformed values of FGFR4 (r = -0.30, P < 0.05, n = 78) 
mRNA abundance and FFL E2 concentrations whereas no significant correlations were 




In GC, positive correlations were detected between FFL concentrations of P4 and 
log-transformed FGFR1c (r = 0.27, P < 0.01, n = 127), FGFR2c (r = 0.21, P < 0.05, n = 129), 
and log-transformed FGFR3c (r = 0.26, P < 0.01, n = 127) mRNA relative abundance. In TC, 
log-transformed values of levels of P4 in FFL were correlated with log-transformed values of 
FGFR1c (r = 0.35, P < 0.05, n = 74) and FGFR4 (r = 0.24, P < 0.05, n = 73) mRNA relative 
abundance. No significant correlations were detected between FFL concentrations of P4 and 
GC FGFR4 mRNA abundance or TC FGFR2c and FGFR3c mRNA abundance. 
In GC, negative correlations were detected between FGFR1c (r = - 0.22, P < 0.05, n 
= 125), log-transformed FGFR2c (r = - 0.54, P < 0.01, n = 127), or log-transformed FGFR3c 
(r = - 0.29, P < 0.01, n = 125) mRNA relative abundance and E2/P4 concentrations ratio in 
FFL. In TC, log-transformed value of FGFR1c mRNA abundance was negatively correlated 
with E2/P4 concentrations ratio in FFL (r = -0.30, P < 0.01, n = 73). No significant 
correlations were detected between FFL E2/P4 concentrations ratio and GC FGFR4 mRNA 
abundance and between FFL E2/P4 concentrations ratio and TC FGFR2c, FGFR3c, or 
FGFR4 mRNA abundance. 
5. Discussion 
Actions of FGFs on the ovary were first reported in the seventies (Gospodarowicz et 
al., 1977a; Gospodarowicz et al., 1977b), when FGF1 was found to stimulate proliferation of 
bovine granulosa and luteal cells. To date, ten members of the FGF family have been shown 
to regulate ovarian folliculogenesis, binding to FGFRs to elicit GC and TC proliferation and 
steroidogenesis (for reviews, see Chaves et al., 2012; Li, 2016). The diversity of roles played 
by FGFs is influenced by the nature of the ligands and the diversity of high affinity FGFRs 
and cofactors that regulate the FGF signaling complex (Givol and Yayon, 1992; Itoh and 
Ornitz, 2004; Dailey et al., 2005; Li et al., 2016). In the present study, FGFR1c and FGFR2c 
mRNA abundance was greater in GC from E2-inactive follicles of all sizes than in GC from 




and medium E2-inactive, and tended to be greater in GC from small E2-inactive than in large 
E2-active follicles. In addition, TC from medium E2-inactive follicles had greater FGFR1c 
mRNA abundance than TC from large E2-active follicles while FGFR1c, FGFR2c, and 
FGFR3c mRNA abundance was greater in TC from medium E2-inactive follicles at late than 
at early growing phase of first dominant follicle. Furthermore, abundance FGFR1c, FGFR2c, 
and FGFR3c mRNA in GC was negatively correlated with FFL E2 concentrations and E2/P4 
ratio and positively correlated with P4 concentrations whereas FGFR1c mRNA abundance in 
TC was also negatively correlated with FFL E2 concentrations and E2/P4 ratio and positively 
correlated with FFL P4 concentrations. Because a follicle’s estrogenic status can be used to 
assess the health of follicles, large E2-active follicles are considered as those selected to 
escape atresia and become dominant (Ireland and Roche, 1982; Spicer and Echternkamp, 
1986), and the present results indicate that FGFR1c, FGFR2c, and FGFR3c are produced in 
greater amounts in GC and TC from subordinate than from dominant follicles, implying a 
pro-atretic or an anti-differentiation role for these receptors. The fact that relative abundance 
of mRNA for FGFR1c and FGFR2c in GC is negatively correlated with size and E2/P4 ratio 
reinforces this idea. 
Relative abundance of GC FGFR4 mRNA was not different among follicles of 
different estrogenic status and sizes, but it was greater in TC from medium E2-inactive 
follicles at days 5 to 6 post-ovulation than at days 3 to 4 post-ovulation. In addition, FGFR4 
mRNA abundance in TC was negatively correlated with size and with FFL E2 concentrations 
and positively correlated with FFL P4 concentrations. Since transcripts for FGFR4 only 
changed in TC, but not in GC, of different groups of follicles across days, it is likely to 
suppose that the action of the ligands that bind to FGFR4 may be more regulated in TC than 
in GC. This is in agreement to previous observations (Buratini et al., 2005a) where FGFR4 
mRNA was only detected in TC, but not in GC or oocytes, from bovine antral follicles. 
Moreover, the fact that FGFR4 mRNA is increasing in E2-inactive follicles as the time of 




preventing differentiation of bovine antral follicles. This is also in agreement with previous 
findings (Buratini et al., 2005a), where transcripts for FGFR4 were greater in TC from small 
than from large antral follicles of cattle.  
Interestingly, many ligands that preferentially bind to FGFR1c, FGFR2c, FGFR3c, 
and FGFR4 appear to be critical regulators of large follicle differentiation and atresia. For 
example, FGF2 (preferentially binding to FGFR1c and FGFR3c), FGF9 (preferentially 
binding to FGFR3c followed by FGFR2c), and FGF17 and FGF18 (preferentially binding to 
FGFR3c followed by FGFR4) inhibit steroidogenic enzyme activity and FSH-stimulated E2 
production by GC in cattle (Vernon and Spicer, 1994; Machado et al., 2009; Portela et al., 
2010; Schreiber and Spicer, 2012). Because E2 is important for GC survival and 
differentiation of dominant follicles (Knecht et al., 1985; Fortune et al., 2004), FGFs 
suppressing E2 production may be playing a role in inducing atresia or preventing 
differentiation of GC in cattle. The fact that some of the ligands that preferentially bind to 
FGFR3c, including FGF9, FGF17, and FGF18, have a greater mRNA abundance in 
subordinate or atretic antral follicles than in dominant follicles in cattle (Machado et al., 2009; 
Portela et al., 2010; Schreiber et al., 2012) reinforces this idea. Furthermore, of the ligands 
mentioned above, FGF18 induced regression of the dominant follicle when injected in vivo 
and increased cleaved caspase-3 in GC in vitro (Portela et al., 2015), which is a major 
downstream effector of apoptosis and serves a marker for GC apoptosis (Feranil et al., 2005), 
confirming the role for this polypeptide in induction of atresia in bovine antral follicles. 
It is noteworthy that some members of the FGF family that preferentially bind to 
FGFR1c and/or FGFR3c are mitogenic factors of ovarian follicle somatic cells of cattle. 
Specifically, FGF1 (Gospodarowicz et al., 1977a) stimulate GC proliferation whereas FGF2 
(Gospodarowicz et al., 1985; Spicer and Stewart, 1996), and FGF9 (Schreiber and Spicer, 
2012; Schreiber et al., 2012) stimulate both GC and TC proliferation. In addition, FGF8 
appears to be stimulating GC proliferation, since it leads to expression of genes related to cell 




FGFR1c and FGFR3c appear to be playing a positive role in early development of bovine 
antral follicles. 
In summary, FGFR1c, FGFR2c, FGFR3c had greater mRNA abundance in GC of 
medium, large, and/or small E2-inactive follicles than in large E2-active follicles and 
FGFR1c, FGFR2c, FGFR3c, FGFR4 mRNA abundance was greater in TC of medium E2-
inactive follicles at late than at early growing phase of first dominant follicle. Furthermore, 
FGFR1c and FGFR4 mRNA relative abundance was greater in TC of medium E2-inactive 
follicles than large E2-active and E2-inactive follicles at late than at early growing phase of 
first dominant follicle. Taken together with the fact that several of their ligands are produced 
in greater amounts by subordinate than by dominant follicles and inhibit E2 production, the 
present findings suggest a role for FGFs and their FGFRs as anti-differentiation factors of 
follicular somatic cells, avoiding the selection of multiple follicles to become dominant in a 
mono-ovulatory species such as cattle.  
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Table 1. Information about primers and probes. 
Gene Oligo Sequence Accession Tm 
(°C) 
FGFR1c FWD AGGTGAACGGGAGTAAGATTGG XM_010820329.2 56.5 




FGFR2c FWD GTTCCAATGCGGAAGTGCTG XM_010820096.2 57.1 




FGFR3c FWD TAACACCACCGACAAGGAGC XM_014478386.1 57.2 
REV CCACGCAGAGTGATGGGAAA 57.6 
Probe TGCGCAATGTCACCTTTGAGGACG 62.0 
FGFR4 FWD CACTGCCCCCCAGAGCTATAC XM_005209123.2 59.5 
REV AGGACCTTGTCCAGTGCCTCTA 59.6 












Fig. 1. Effects of follicular size (Lg = Large; Md = Medium; Sm = Small) and E2 
status (EA = estrogen active; EI = estrogen inactive) on FGFR1c, FGFR2c, FGFR3c, and 
FGFR4 mRNA relative abundance in bovine granulosa cells. Panel A: Effects of follicular 
size and E2 status on FGF1c mRNA in bovine granulosa cells (GC); n = 16, 33, 64, and 29 
and for Lg-EA, Lg-EI, Md-EI and Sm-EI, respectively. Panel B: Effects of follicular size and 
E2 status on FGF2c mRNA in bovine GC; n = 16, 33, 62, and 28 for Lg-EA, Lg-EI, Md-EI 
and Sm-EI, respectively. Panel C: Effects of follicular size and E2 status on FGF3c mRNA in 
bovine GC; n = 16, 32, 61, and 28 for Lg-EA, Lg-EI, Md-EI and Sm-EI, respectively. Panel 
D: Effects of follicular size and E2 status on FGF4 mRNA in bovine GC; n = 15, 28, 61, and 
29 for Lg-EA, Lg-EI, Md-EI and Sm-EI, respectively. Values are normalized to constitutively 
expressed 18S ribosomal RNA and are least squares means ± pooled SEM of values averaged 
across day 3 to 4 and day 5 to 6 post-ovulation.  abcWithin a panel, means without a common 


























(B) FGFR2c in GC 
(D) FGFR4 in GC (C) FGFR3c in GC 


































Fig. 2. Effects of follicular size (Lg = Large; Md = Medium; Sm = Small) and E2 
status (EA = estrogen active; EI = estrogen inactive) on FGFR1c, FGFR2c, FGFR3c, and 
FGFR4 mRNA abundance in bovine theca cells (TC) on different days post-ovulation. Panel 
A: Effects of follicular size and E2 status on FGF1c mRNA in bovine TC; n = 9, 10, and 27 
for Lg-EA, Lg-EI, and Md-EI, respectively, for day 3-4; n = 4, 11, and 22 for Lg-EA, Lg-EI, 
and Md-EI, respectively, for day 5-6. Panel B: Effects of follicular size and E2 status on 
FGFR2c mRNA in bovine TC; n = 9, 12, and 23 for Lg-EA, Lg-EI, and Md-EI, respectively, 
for day 3-4; n = 4, 10, and 20 for Lg-EA, Lg-EI, and Md-EI, respectively, for day 5-6. Panel 
C: Effects of follicular size and E2 status on FGFR3c mRNA in bovine TC; n = 8, 12, and 26 
for Lg-EA, Lg-EI, and Md-EI, respectively, for day 3-4; n = 4, 11, and 22 for Lg-EA, Lg-EI, 
and Md-EI, respectively, for day 5-6. Panel D: Effects of follicular size and E2 status on 
FGFR4 mRNA in bovine TC; n = 9, 11, and 25 for Lg-EA, Lg-EI, and Md-EI, respectively, 
for day 3-4; n = 4, 11, and 22 for Lg-EA, Lg-EI, and Md-EI, respectively, for day 5-6. Values 
are normalized to constitutively expressed 18S ribosomal RNA and are least squares means ± 
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TRANSCRIPTOME PROFILING OF BOVINE THECA CELLS TREATED 
WITH FIBROBLAST GROWTH FACTOR 9 
 
1. Abstract 
Fibroblast growth factor 9 (FGF9), a member of a large family of single chain 
polypeptide factors, controls several functions in many different tissues of mammals. In the 
ovaries of cattle, FGF9 appears to be acting as an anti-differentiation factor, stimulating in 
vitro proliferation of granulosa (GC) and theca (TC) cells while suppressing steroidogenesis 
of these cells in the presence of insulin-like growth factor 1 (IGF-1). Also, FGF9 mRNA 
abundance in GC and TC changes according to the size and estrogenic status of follicles and 
days post-ovulation in cattle. Nevertheless, information about signaling mechanisms activated 
by FGF9 in TC is somewhat lacking. Therefore, the objective of this study was to investigate 
how bovine TC from large ovarian follicles respond to exogenous FGF9 in vitro. In order to 
detect differentially expressed transcripts by TC following FGF9 in vitro treatment, 
microarray technology was utilized. Ovaries were obtained from beef heifers at a local 
abattoir, TC were isolated from large antral follicles (8.1-22 mm in surface diameter), and 
cultured in basal medium containing 10% FCS for 48 h prior to treatment with or without 30 
ng/mL of FGF9 for 24 h in the presence of LH and IGF-1. Following treatment, total RNA 
was extracted from TC and processed for microarray. A total of eight chips (Affymetrix 
GeneChip Bovine Genome Arrays) were hybridized with RNA extracted from four biological 
replicates of the same number of TC pools in a paired design for the two treatments (FGF9 or 
control). Affymetrix GeneChip Operating Software was used to quantitate each GeneChip® 
and summary intensities for each probe were loaded into DNA-Chip Analyzer (dChip) for 




between treatments. Analysis of hybridized GeneChip Bovine Genome arrays comparing 
FGF9-treated TC with control TC identified 355 differentially expressed transcripts, with 164 
elements up-regulated and 191 elements down-regulated by FGF9. The QIAGEN’s 
Ingenuity® Pathway Analysis was utilized to investigate how FGF9 treatment affects 
molecular pathways, biological functions, and the connection between molecules in bovine 
TC. The IPA software identified differentially expressed transcripts in 346 pathways in 
response to FGF9 in TC involved in functions such as cell cycle, growth, development, 
proliferation, death and survival, cellular assembly and organization, and steroidogenesis. 
Networks of differentially expressed transcripts unveiled interesting relationships among 
genes related to cellular growth and proliferation and to steroidogenesis. Overall, genes, 
pathways, and networks identified in this study painted an interesting picture of how FGF9 
regulates folliculogenesis, providing novel candidates for further investigation of FGF9 
functions in the ovary of cattle. 
Keywords: cattle; cell proliferation; Fibroblast growth factor-9 (FGF9); microarray; 
steroidogenesis; theca cell. 
2. Introduction 
Fibroblast growth factors (FGFs) constitute a large family of single chain polypeptide 
factors present in both vertebrates and invertebrates (Ornitz and Itoh, 2001; Itoh and Ornitz, 
2011; Li et al., 2016). Currently, 22 different members have been reported in mammals 
(FGF1 to 23), binding to high affinity receptors and several cofactors to play a variety of roles 
in various tissues (Givol and Yayon, 1992; Itoh and Ornitz, 2004; Dailey e al., 2005). 
Fibroblast growth factor 9 (FGF9) was originally isolated from human glioma cells 
and characterized as a mitogenic factor (Miyamoto et al., 1993). In the last two decades, 
research has shown that this polypeptide plays diverse roles in many different tissues, 
including heart (Lavine et al., 2005; Singla et al., 2015), cartilage (Weksler et al., 1999), liver 




Drummond et al., 2007) and nervous systems (Reuss et al., 2000; Meier et al., 2014). In these 
tissues, FGF9 binds to FGF receptors (FGFR1c, FGFR2c, FGFR3c, FGFR3b, and FGFR4) to 
activate specific tyrosine residues and downstream intracellular signaling pathways, including 
the RAS-MAPK, PI3K-AKT, PLCγ, and STAT pathways, which regulate cell proliferation, 
survival, metabolism, and differentiation (Ornitz and Itoh, 2015). In fact, FGF9 has been 
shown to regulate sex determination (Kim et al., 2006), steroidogenesis (Schreiber and Spicer, 
2012; Schreiber et al., 2012; Lai et al., 2014), tissue development (Harada et al., 2009), 
wound healing (Zheng et al., 2014), and even mood disorders (Aurbach et al., 2015). 
Moreover, expression of FGF9 has been related to brain (Todo et al., 1998) and gastric (Sun 
et al., 2015) cancers. 
In the ovaries, FGF9 was first described to be present in murine corpora lutea, 
stromal, and theca cells (TC) and was observed to stimulate progesterone (P4) production by 
granulosa cells (GC) in a paracrine way (Drummond et al., 2007). In porcine GC, FGF9 in the 
presence of insulin-like growth factor 1 (IGF-1) stimulated cell proliferation and 
steroidogenesis (Evans et al., 2014). In cattle, FGF9 has been suggested to be an anti-
differentiation factor by stimulating in vitro proliferation of TC and GC while suppressing P4 
production by TC and GC and estradiol (E2) production by GC in the presence of IGF-1 
(Schreiber and Spicer, 2012; Schreiber et al., 2012). Abundance of FGF9 mRNA in GC and 
TC is hormonally regulated (Schreiber and Spicer, 2012; Schreiber et al., 2012) and changes 
according to the size and estrogenic status of follicles and days post-ovulation in cattle 
(Schütz et al., 2016, unpublished data). Hence, it seems clear that FGF9 is an important 
regulator of ovarian function in mammals, but its role may differ between monotocous and 
polytocous animals. Nevertheless, detailed information about signaling mechanisms activated 
by FGF9 in TC is lacking. 
The technology of microarray is a powerful tool for one to investigate how a specific 
cell type reacts to certain stimuli, enabling the simultaneous measurement of thousands of 




bovine TC from large ovarian follicles respond to exogenous FGF9 in vitro. Unveiling 
signaling pathways activated by FGF9 in TC may provide valuable information to understand 
molecular aspects of cell proliferation, steroidogenesis, and apoptosis in a mono-ovulatory 
species such as cattle. 
3. Material and Methods 
Reagents and Hormones 
The reagents used in cell culture were Ham’s F-12 (F12), DMEM, gentamicin, 
glutamine, sodium bicarbonate, trypan blue, deoxyribonuclease (DNase), and collagenase 
from Sigma-Aldrich Chemical Co. (St. Louis, MO), and fetal calf serum (FCS) from 
Equitech-Bio, Inc. (Kerrville, TX). The hormones used in cell culture were recombinant 
human FGF9 and IGF-1 (R&D Systems, Minneapolis, MN; all carrier-free), and ovine LH 
(NIDDK-oLH-26; activity: 1.0× NIH-LH-S1 U/mg) from the National Hormone & Pituitary 
Program (Torrance, CA). 
Cell Collection and In Vitro Culture 
Ovaries were obtained from beef heifers at a local abattoir and transported to the 
laboratory in 0.9% saline with 1% streptomycin/penicillin on ice. TC were isolated from large 
antral follicles (8.1-22 mm in surface diameter) with adequate vascularity and moderately 
transparent follicular fluid as previously described (Stewart et al., 1995; Lagaly et al., 2008). 
Briefly, follicles were bisected, GC were scraped free from the theca interna and the theca 
interna tissue was removed via microdissection and enzymatically digested for 1 h at 37 °C 
on a rocking platform. Non-digested thecal tissue was removed via filtration through a 149 
µm mesh screen (Gelman Sciences, Ann Arbor, MI, USA). TC were then centrifuged at 50 x 
g for 7 min, washed twice in medium (1:1 DMEM and F12 containing 2.0 mM glutamine, 
0.12 mM gentamicin, and 38.5 mM sodium bicarbonate), and resuspended in serum-free 
medium containing collagenase and DNase at 1.25 and 0.5 mg/mL, respectively, to prevent 




Viability of TC was determined by trypan blue exclusion test and viable cells were 
transferred to Falcon 24-well multiwell plates (Becton Dickinson, Lincoln Park, NJ, USA) 
with medium containing 10% FCS. Cells were cultured at 38.5 °C in a humidified 95% air 
and 5% CO2 environment for the first 48 h with a medium change at 24 h. Following, TC 
were washed twice in serum-free medium and cultured in 1 mL serum-free medium 
containing 15 ng/mL of LH and 15 ng/mL of IGF-1 with or without 30 ng/mL of FGF9 for 24 
h. 
RNA Extraction, Microarray and Statistical Analyses 
Following treatment, TC were lysed with 0.5 mL of TRIzol® Reagent (Life 
Technologies Inc., Gaithersburg, MD) and total RNA was extracted as previously described 
(Lagaly et al., 2008; Grado-Ahuir et al., 2009). Affymetrix GeneChip Bovine Genome Arrays 
(Affymetrix, Santa Clara, CA) were used for the microarray as previously described (Grado-
Ahuir et al., 2011). This particular array is designed to monitor expression of approximately 
23,000 bovine transcripts through 24,072 probe sets. A total of eight chips were hybridized 
with RNA extracted from four biological replicates of the same number of TC pools in a 
paired design for the two treatments (FGF9 or control). Each pool of TC was generated from 
5 to 7 large follicles. The processing of RNA, including RNA purification and hybridization 
of microarray slides, was performed by the University of Tulsa Microarray Core Facility. 
Affymetrix GeneChip Operating Software (GCOS ver. 1.1.1, Affymetrix, Santa Clara, CA) 
was used to quantitate each GeneChip®. Summary intensities for each probe were loaded into 
DNA-Chip Analyzer (dChip), version 1.3, for normalization, standardization, and analysis. 
Paired t-tests were calculated using dChip to evaluate significant differences between 
treatments as previously described (Grado-Ahuir et al., 2009; Grado-Ahuir et al., 2011). 
Microarray Functional Data Analysis 
To explore the biological knowledge associated with the statistically significant probe 




comparisons in dChip, the QIAGEN’s Ingenuity® Pathway Analysis (IPA®; QIAGEN 
Redwood City, http://www.qiagen.com/ingenuity) was utilized. The analyses were performed 
to investigate how FGF9 treatment affects molecular pathways, biological functions, and the 
connection between molecules in bovine TC. 
4. Results 
Analysis of hybridized GeneChip Bovine Genome arrays comparing FGF9-treated 
TC with control identified 355 differentially expressed transcripts (p < 0.05 according to t-
tests and at least 1.3-fold change), with 164 elements up-regulated and 191 elements down-
regulated. The IPA software utilized a total of 345 differentially expressed transcripts in its 
analysis. The 20 genes found to be the most up- and down-regulated among the differentially 
expressed genes are summarized in Table 1 and Table 2, respectively, in order of fold-change.  
Identification of Molecular Canonical Pathways Altered by FGF9 Treatment 
The IPA software identified differentially expressed transcripts in 346 pathways in 
response to FGF9 in TC. The top ten canonical pathways affected by FGF9 (based on p-value 
on negative log scale) are shown in Fig. 1. The main functions associated with the top altered 
pathways include cellular assembly and organization, and cell cycle, growth, development, 
proliferation, death and survival. In addition to these, it is noteworthy to mention that FGF9 
treatment affected transcripts for genes in pathways related to ovarian steroidogenesis, 
including: Wnt/β-catenin signaling, IGF-1 signaling, PI3K/AKT signaling, TGF-β signaling, 
EGF signaling, and pregnenolone biosynthesis.  
Identification of Biological Functions Altered by FGF9 Treatment 
The IPA identified 500 annotated biological functions for the differentially expressed 
transcripts altered by FGF9 in vitro treatment in bovine TC. The top ten identified biological 
functions predicted to be increased by FGF9 in TC are shown in Fig. 2 in order of activation 




expression, but only z-scores greater than 2 or smaller than -2 are considered significant for 
predicted activation state). 
Because FGF9 has been reported to stimulate bovine TC proliferation at the same 
time that it suppresses steroidogenesis (Schreiber et al., 2012), special attention was given to 
functions related to cell fate, including cell proliferation, survival, differentiation, death, and 
apoptosis among the altered identified biological functions (Fig. 3). Nevertheless, although 
cell proliferation, survival, and differentiation functions all had a positive activation z-score, 
only cell proliferation and cell survival were predicted to be increased by FGF9 in TC (i.e., 
with z-scores greater than 2). 
Identification of Molecular Networks Affected by FGF9 Treatment 
Seeking to understand how molecules affected by FGF9 connect to each other and 
relate to specific functions, we analyzed the networks generated by IPA. The differentially 
expressed transcripts affected by FGF9 were categorized in 21 different networks. The top 10 
networks according to p-score are shown in Fig. 4. 
In order to assess how FGF9 treatment may affect ovarian function, special attention 
was given to networks involving cell proliferation and steroidogenesis, two actions already 
reported to be affected by FGF9 in bovine TC (Schreiber et al., 2012). These networks are 
shown in Figs. 5 and 6, respectively. For cell proliferation, up-regulated (p < 0.05) transcripts 
were CCND1, FZD5, MYB, CASP3, FRMD4A, ACKR3, JADE2, RBPJ, HAUS8, ARRDC2, 
DENND2A, H2AFZ, while down-regulated (p < 0.05) transcripts were HLA-DRA, AARSD1, 
MLF1, JADE3, UBE2D4, PPP2R2B, NQO1, HMOX1, AGTR1, RNF150, SOD, KCNAB1. For 
steroidogenesis, up-regulated genes (p < 0.05) by FGF9 were: TFPI, VLDR, SLC38A2, 
ACSL4, PRKCA, ARG2, PER2 while down-regulated genes (p < 0.05) by FGF9 were: 
COL14A1, OGN, IGF2, SORT1, AGTR1, GPIIB-IIIA, CYP2C9, STAR, CYP11A1, SIRT3, 






FGF9 is a powerful mitogen that stimulates cell proliferation in many tissues and has 
been implicated in many types of cancer (Todo et al., 1998; Hendrix et al., 2006; Sun et al., 
2015). In the ovary, FGF9 has been reported to stimulate proliferation of both GC and TC 
(Schreiber and Spicer, 2012; Schreiber et al., 2012). Hence, it is no surprise that, based on Z-
activation scores, cell proliferation was the biological function most affected by FGF9 in the 
present analysis (Fig. 2), with 157 out of 346 differentially expressed transcripts related with 
this function. 
The fact that the gene encoding for cyclin D1 (CCND1), a protein required for 
progression of the G1 phase of the cell cycle (Baldin et al., 1993) that has been previously 
detected in proliferating murine TC, but not GC (Robker and Richards, 1998), was the most 
up-regulated transcript by FGF9 treatment in the present microarray further supports the 
importance of FGF9 in stimulating TC proliferation. In addition, two other genes among the 
top 20 up-regulated transcripts by FGF9 (FZD5 and MYB) are related to cell proliferation (as 
shown in Table 1 and Fig. 5). In fact, FZD5 encodes the protein Frizzled family receptor 5, a 
cell-surface receptor that interacts with Wnt proteins to stimulate cell proliferation of human 
endometrial adenocarcinoma cells (Carmon and Loose, 2008) and bovine TC (Spicer, 2016), 
while MYB (v-myb myeloblastosis viral oncogene homolog) encodes the protein c-Myb, a 
transcription factor that stimulates cell proliferation while suppressing apoptosis and 
differentiation of a variety of cell types, including human myeloid leukemia cells (Anfossi et 
al., 1989; Lyon et al., 1994) and human breast cancer cells (Drabsch et al., 2010). The protein 
c-Myb is a positive regulator of CCND1 in human liver cancer (Zhang et al., 2012) and breast 
carcinoma (Mitra et al., 2016) cells. Bartunek and colleagues (2002) reported that MYB and 
FGF2 cooperate to sustain avian hematopoietic cell proliferation while preventing them to 
differentiate into red blood cells. Hence, FGF9 appears to be stimulating the progression of 
the G1 phase of the cell cycle for bovine TC proliferation through the Wnt signaling pathway 




has been reported to increase FGF9 mRNA abundance in bovine TC (Schreiber et al., 2012), 
reinforcing the association between FGF9 and the Wnt signaling pathway. 
Another intriguing observation from the cell proliferation Network generated by IPA 
(Fig. 5) is the fact that transcripts for caspase-3 (CASP3) were increased in TC in response to 
FGF9. Indeed, although CASP3 is a major downstream effector of apoptosis in GC of atretic 
follicles, CASP3 immunostaining has also been reported in TC of healthy follicles (Boone 
and Tsang, 1998). Reports imply that CASP3 may be involved in selective destruction of 
organelles and may be enhancing cell survival and proliferation in certain situations 
(Perfettini and Kroemer, 2003; Kuranaga, 2011). Interestingly, CASP3 cleaves the cyclin-
dependent kinase inhibitor 1B (p27Kip1), a mammalian regulator of the cell cycle that induces 
G1 arrest, thus stimulating lymphoid cell proliferation (Frost et al., 2001). Because p27Kip1 
decreases during TC proliferation and increases during TC terminal differentiation (Robker 
and Richards, 1998), the present data indicate that, like with lymphoid cells, CASP3 may be 
stimulating bovine TC proliferation by preventing p27Kip1 to arrest cells at G1. A lack of 
change in p27Kip1 mRNA following FGF9 treatment supports a post-transcriptional regulation 
of p27Kip1. Furthermore, MIR221, one of the top up-regulated genes in the present study, has 
been reported to down-regulate p27Kip1, via prevention of translation, in human hepatocellular 
carcinoma (Fornari et al., 2008).  
It is also noteworthy that the genes HMOX1 and NQO1 were down-regulated by 
FGF9, as shown in the cell proliferation Network (Fig. 5). These genes are antioxidant and 
cytoprotective, being activated by the transcription activator NRF2 in response to oxidative 
stress in order to protect the cells (Attucks et al., 2014). Not by coincidence, NRF2-mediated 
oxidative stress response is among the top canonical pathways affected by FGF9 in the 
present study (Fig. 1). Reactive oxygen species (ROS) are constantly produced during 
metabolic processes and it is now well accepted that ROS at high concentrations are 
cytotoxic, but, at moderate concentrations, ROS play a role in signal transduction processes, 




ROS have been shown to stimulate the initiation of apoptosis in GC of antral follicles (Devine 
et al., 2012; Zhang et al., 2016). Nevertheless, in theca-interstitial cells, generation of ROS is 
required to maintain cell proliferation, and a reduction in the level of ROS inhibits cell 
proliferation (Duleba et al., 2004). Hence, the reduction in transcripts for HMOX1 and 
NQO1, factors that reduce ROS concentrations, by FGF9 observed in the present study 
suggests that ROS may be important for bovine TC proliferation. This idea is further 
supported by the fact that ROS mediate FGF2 biological effects in chondrocytes (as reviewed 
by Sainz et al., 2012). In addition, Cui and co-authors (2015) recently reported that NQO1 is 
frequently up-regulated in human ovarian carcinomas, supporting the idea that controlled 
regulation of NQO1 may play an important role in ovarian function. 
FGF9 has also been reported as a regulator of steroidogenesis by murine, bovine, and 
porcine follicular somatic cells (Drummond et al., 2007; Schreiber and Spicer, 2012; 
Schreiber et al., 2012; Evans et al., 2014). In bovine GC, FGF9 decreases IGF-1 plus FSH-
induced E2, P4, and pregnenolone production while decreasing mRNA abundance for the 
steroidogenic enzyme CYP11A1 and for the FSH receptor (FSHR) of both small (1-5 mm) 
and large (8-22 mm) antral follicles (Schreiber and Spicer, 2012). In bovine TC, FGF9 
decreases IGF-1 plus LH-induced P4 and androstenedione (A4) production while decreasing 
mRNA abundance for the steroidogenic enzymes CYP11A1 and CYP17A1 and for the LH 
receptor (LHCGR) of large antral follicles (Schreiber et al., 2012). Therefore, the fact that 
CYP11A1 is among the top down-regulated genes is not surprising (Table 2). In addition, 
other genes related to steroidogenesis of TC were down-regulated by FGF9 in this study (Fig. 
6), including the genes encoding for steroidogenic acute regulatory protein (STAR), insulin-
like growth factor 2 (IGF2), angiotensin II receptor, type I (AGTR1), frizzled class receptor 4 
(FZD4), and cytochrome P450, family 2, subfamily C, polypeptide 9 (CYP2C9). STAR is 
responsible for mediating the transport of cholesterol to mitochondria (Lin et al., 1995); IGF2, 
AGTR1 and FZD4 appear to be important to P4 production, since both IGF2 (Spicer et al., 




while FZD4 knockout mice have lower P4 production (Hsieh et al., 2005); CYP2C9 is 
involved in catabolism of P4 (Yamazaki and Shimada, 1997). Hence, these observations 
suggest that FGF9 affects several genes that may act in concert to suppress P4 and A4 
production by bovine TC. The fact that STAR was down-regulated in this study is in contrast 
to a previous report by our group in FGF9-treated TC and requires further investigation 
(Schreiber et al., 2012). Finally, the observation that the frizzled proteins encoding genes 
FZD2, FZD4, and SRFP2 were down-regulated in the steroidogenesis Network suggests that 
these genes can be also linking the Wnt signaling pathway with steroidogenesis in TC, but 
this hypothesis also requires further investigation. Recent studies support this idea by 
showing that WNT5A increases androstenedione production by bovine TC (Spicer, 2016).  
Steroidogenesis by TC and GC of large antral follicles is crucial for follicular 
differentiation (Knecht et al., 1984; Evans and Fortune, 1997; McGee and Hsueh, 2000; 
Young and McNeilly, 2010). Since FGF9 decreases synthesis of P4 and A4 and reduces 
mRNA abundance for both LHCGR and CYP17A1 (Schreiber et al., 2012), critical factors for 
TC differentiation in preovulatory follicles (Richards, 1994; McGee and Hsueh, 2000), it 
seems likely to suppose that FGF9 acts as an anti-differentiation factor of TC of large antral 
follicles, at least in cattle. This idea is further reinforced by the observation that abundance of 
bovine FGF9 mRNA is greater in TC of all sizes of E2-inactive follicles (i.e., future atretic 
follicles) than in large E2-active follicles (i.e., dominant follicles) at an early growing phase 
of the first dominant follicle (Schütz et al., 2016). Thus, the fact that FGF9 up-regulated 
CCND1 and MYB, factors that suppress cell differentiation while stimulating cell proliferation 
(Lyon et al., 1994; Robker and Richards, 1998), together with the observation that FGF9 was 
not predicted to increase TC differentiation (Fig. 3) in the current study corroborates the idea 
that FGF9 is stimulating bovine TC proliferation rather than differentiation.  
In summary, the current microarray study allowed the identification of 345 
differentially expressed transcripts in bovine TC following in vitro FGF9 treatment, several of 




provide an interesting picture of how FGF9 promotes TC proliferation while suppressing cell 
differentiation. The investigation of the candidate genes and pathways unraveled here by IPA 
will not only provide an insight of how FGF9 plays a role in folliculogenesis in cattle, but will 
also help to unveil how this growth factor affects pathological conditions such as cystic 
ovarian follicles and ovarian cancer. 
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Table 1. 20 most up-regulated genes by FGF9 treatment in bovine TC. 
 
 Probe set Gene symbol Gene Name Fold 
change 
P-value 
1 Bt.16538.2.A1_at CCND1 Cyclin D1 4.96 0.0000569 
2 Bt.12927.1.S1_at HAS2 hyaluronan synthase 
2 
3.90 0.000803649 
3 Bt.1817.1.S1_at ETV1 Ets variant 1 3.49 0.00142088 
4 Bt.996.1.S1_at --- transcribed locus 3.25 0.00080151 
5 Bt.19826.1.A1_at --- transcribed locus 3.23 0.0210203 







7 Bt.29956.1.A1_at BMP2 bone morphogenetic 
protein 2 
2.98 0.00193277 
8 Bt.10212.1.S1_at PHLDA1 Pleckstrin 
homology-like 
domain, family A, 
member 1 
2.97 0.000000737 
9 Bt.3051.1.S1_at --- Transcribed locus 2.92 0.0000611 









11 Bt.16100.1.S1_at FZD5 Frizzled family 
receptor 5 
2.81 0.000317748 




























16 Bt.11109.1.S1_at MIR221 microRNA mir-221 2.43 0.0000000273 






18 Bt.17951.1.A1_at --- Transcribed locus 2.36 0.0257273 






20 Bt.20507.1.S1_at CYP26B1 cytochrome P450, 
family 26, subfamily 












Table 2. 20 most down-regulated genes by FGF9 treatment in bovine TC. 
 
 Probe set Gene 
symbol 
Gene Name Fold 
change 
P-value 
1 Bt.4939.1.S1_at SFRP2 secreted frizzled-related 
protein 2 
-4.09 0.00392234 
2 Bt.7190.1.S1_at CYP11A1 cytochrome P450, 
family 11, subfamily A, 
polypeptide 1 
-4.09 0.0236564 
3 Bt.13482.1.S1_at NOV nephroblastoma 
overexpressed 
-3.25 0.0116386 
4 Bt.13855.2.S1_at ADAMDEC1 ADAM-like, decysin 1 -3.25 0.00490709 
5 Bt.11656.1.S1_at CGN cingulin -3.06 0.000463423 
6 Bt.19661.1.S1_at PPP2R2B protein phosphatase 2, 
regulatory subunit B, 
beta 
-3.01 0.000310913 
7 Bt.20574.1.S1_at AQP11 aquaporin 11 -2.99 0.00102593 
8 Bt.10021.1.S1_at MYL7 myosin, light chain 7, 
regulatory 
-2.72 0.0261566 
9 Bt.19322.1.A1_at COL4A6 collagen, type IV, alpha 
6 
-2.69 0.0213395 
10 Bt.5341.1.S1_at OGN osteoglycin -2.68 0.00729922 
11 Bt.23113.1.A1_at --- transcribed locus -2.66 0.0000184 
12 Bt.22768.1.A1_at SVEP1 sushi, von Willebrand 




13 Bt.24211.1.A1_at ASPN asporin -2.61 0.00459269 
14 Bt.1745.1.S1_at KRT18 keratin 18 -2.59 0.00608511 
15 Bt.7042.1.S1_at NPVF neuropeptide VF 
precursor 
-2.58 0.00210952 
16 Bt.16495.1.A1_at COL4A5 collagen, type IV, alpha 
5 
-2.56 0.0140642 
17 Bt.5530.1.S1_at DHRS3 dehydrogenase/reductase 
(SDR family) member 3 
-2.49 0.00124302 
18 Bt.27645.1.A1_at ISM1 isthmin 1 homolog 
(zebrafish) 
-2.46 0.00446444 
























Fig. 1. Top 10 canonical pathways altered by FGF9 in bovine TC identified by IPA. 



















































Fig. 2. Top 10 biological functions for the differentially expressed transcripts altered 
by FGF9 treatment in bovine TC identified by IPA. Numbers to the right on the bars indicate 


































Fig. 3. Biological functions related to cell fate altered by FGF9 in bovine TC 
identified by IPA. Among these functions, based on activation z-score, only proliferation of 
cell and cell survival were predicted to be significantly increased in response to FGF9 in TC. 
The numbers on the top of each bar indicate the number of differentially expressed transcripts 

































Fig. 4. Top 10 networks generated by IPA according to score. The greater the area in 
































Fig. 5. Network of differentially expressed transcripts related to cellular growth and 
proliferation (Network 3). The bold lines show a direct association among molecules while 
dashed lines show an indirect association among the molecules. Different shapes of molecules 
indicate different functions. Significantly up-regulated genes (p < 0.05) by FGF9 in this 
network were: CCND1, FZD5, MYB, CASP3, FRMD4A, ACKR3, JADE2, RBPJ, HAUS8, 
ARRDC2, DENND2A, H2AFZ; significantly down-regulated genes (p < 0.05) by FGF9 in this 
network were: HLA-DRA, AARSD1, MLF1, JADE3, UBE2D4, PPP2R2B, NQO1, HMOX1, 
















Fig. 6. Network of differentially expressed transcripts related to steroidogenesis 
(Network 15: Lipid metabolism, molecular transport, small molecule biochemistry). The bold 
lines show a direct association among molecules while dashed lines show an indirect 
association among the molecules. Different shapes of molecules indicate different functions. 
Significantly up-regulated genes (p < 0.05) by FGF9 in this network were: TFPI, VLDR, 
SLC38A2, ACSL4, PRKCA, ARG2, PER2; significantly down-regulated genes (p < 0.05) by 
FGF9 in this network were: COL14A1, OGN, IGF2, SORT1, AGTR1, GPIIB-IIIA, CYP2C9, 
STAR, CYP11A1, SIRT3, RIMS1, ARID5B. Frizzled molecules were either down-regulated 
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SUMMARY AND CONCLUSION 
Several factors produced by the ovarian follicular somatic cells, granulosa 
(GC) and theca cells (TC), are known to regulate follicular development, including 
the fibroblast growth factors (FGFs). Among these, FGF9 has been characterized as 
an anti-differentiation factor of bovine follicles, stimulating both GC and TC 
proliferation while suppressing hormone-stimulated steroidogenesis. Nevertheless, 
whether production of FGF9 by ovarian follicular cells changes during 
folliculogenesis is unknown. Therefore, we investigated changes in FGF9 mRNA 
abundance in bovine GC and TC during development of first dominant follicle. Our 
findings reinforce the idea that FGF9 is acting as an anti-differentiation factor, since 
its mRNA abundance was greater in subordinate than in large dominant follicles. In 
addition, seeking to have a comprehensive view of the role of FGFs in 
folliculogenesis, we investigated how transcripts for selected FGF receptors 
(FGFR1c, FGFR2c, FGFR3c, and FGFR4) change in GC and TC during development 
of the first dominant follicle of cattle. We found that mRNA for these FGFRs are also 
greater in subordinate than in large dominant follicles, suggesting that, similar to 
FGF9, FGFRs may contribute to follicular selection in cattle. Finally, we investigated 
how FGF9 affects biological functions of TC through the use of microarray 
technology and bioinformatics tools such as Ingenuity Pathway Analysis. We were 




steroidogenesis, cell proliferation, and survival. Taken together, these findings 
support the idea that FGF9 regulates selection of the dominant follicle in cattle. 
Possible applications of this research include using FGF9 in protocols of 
superovulation and the manipulation of follicular waves in cattle in order to improve 
reproductive efficiency. Furthermore, genes and pathways unveiled by microarray 
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